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Summary
Background Few studies have reported long-term data on mortality rates for children admitted to hospital with 
pneumonia in Africa. We examined trends in case fatality rates for all-cause clinical pneumonia and its risk factors 
in Malawian children between 2001 and 2012.
Methods Individual patient data for children (<5 years) with clinical pneumonia who were admitted to hospitals 
participating in Malawi’s Child Lung Health Programme between 2001 and 2012 were recorded prospectively on a 
standardised medical form. We analysed trends in pneumonia mortality and children’s clinical characteristics, and 
we estimated the association of risk factors with case fatality for children younger than 2 months, 2–11 months of 
age, and 12–59 months of age using separate multivariable mixed eﬀ ects logistic regression models.
Findings Between November, 2012, and May, 2013, we retrospectively collected all available hard copies of yellow 
forms from 40 of 41 participating hospitals. We examined 113 154 pneumonia cases, 104 932 (92∧7%) of whom had 
mortality data and 6903 of whom died, and calculated an overall case fatality rate of 6·6% (95% CI 6·4–6·7). The 
case fatality rate signifi cantly decreased between 2001 (15·2% [13·4–17·1]) and 2012 (4·5% [4·1–4·9]; ptrend<0·0001). 
Univariable analyses indicated that the decrease in case fatality rate was consistent across most subgroups. In 
multivariable analyses, the risk factors signifi cantly associated with increased odds of mortality were female sex, 
young age, very severe pneumonia, clinically suspected Pneumocystis jirovecii infection, moderate or severe 
underweight, severe acute malnutrition, disease duration of more than 21 days, and referral from a health centre. 
Increasing year between 2001 and 2012 and increasing age (in months) were associated with reduced odds of 
mortality. Fast breathing was associated with reduced odds of mortality in children 2–11 months of age. However, 
case fatality rate in 2012 remained high for children with very severe pneumonia (11·8%), severe undernutrition 
(15·4%), severe acute malnutrition (34·8%), and symptom duration of more than 21 days (9·0%).
Interpretation Pneumonia mortality and its risk factors have steadily improved in the past decade in Malawi; 
however, mortality remains high in specifi c subgroups. Improvements in hospital care may have reduced case 
fatality rates though a lack of suﬃ  cient data on quality of care indicators and the potential of socioeconomic and 
other improvements outside the hospital precludes adequate assessment of why case-fatality rates fell. Results 
from this study emphasise the importance of eﬀ ective national systems for data collection. Further work combining 
this with data on trends in the incidence of pneumonia in the community are needed to estimate trends in the 
overall risk of mortality from pneumonia in children in Malawi.
Funding Bill & Melinda Gates Foundation.
Copyright © Lazzerini et al. Open Access article distributed under the terms of CC BY.
Introduction
Pneumonia is the leading cause of morbidity and 
mortality in post-neonatal children under 5 years of age.1 
According to the most recent estimates,1 0·9 million 
children died of pneumonia in 2013, and more than 95% 
of these deaths happened in low-income and middle-
income countries.1,2
Few data are available to show the epidemiology and 
public health burden of paediatric pneumonia cases in 
African hospitals. A recent systematic review3 identifi ed 
only 11 studies reporting data on mortality from acute 
lower respiratory infections in hospitals within the 
African region; these reports were unpublished, with 
very few exceptions,4 and observation times were limited 
to 2–3 years.3
Malawi is currently one of the poorest countries in 
sub-Saharan Africa. However, according to national 
statistics,5 major progress was made in the past 15 years, 
and Malawi is on track to reach the Millennium 
Development Goal 4 of a two-thirds reduction in 
under-5 year mortality from 1990 to 2015.
In 2000, the Malawi Ministry of Health implemented a 
standardised medical chart for children younger than 
5 years who were admitted to hospital with clinical 
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pneumonia. These data have been routinely collected 
prospectively but never comprehensively analysed. We 
have analysed the available individual patient data from 
hospitals in Malawi that implemented this routine 
system of data collection between 2001 and 2012, with the 
objective of describing trends in case fatality rates for all-
cause clinical pneumonia and its risk factors in children 
younger than 5 years.
Methods
Study design and participants
In 2000, the Malawi Ministry of Health’s Acute Respiratory 
Infection unit (ARI) and the International Union Against 
Tuberculosis and Lung Disease implemented the Child 
Lung Health Programme (CLHP),6,7 which included two 
key elements: national clinical pneumonia management 
guidelines8 adapted from WHO guidelines;9,10 and the 
implementation of a standardised patient chart (the 
yellow form) to be used as an oﬃ  cial medical fi le for each 
child admitted to hospital for pneumonia. CLHP clinical 
pneumonia was defi ned according to Malawi ARI 
guidelines (panel). The yellow form contains individual 
patient data such as demographic variables, clinical 
signs and symptoms, pneumonia disease severity, 
comorbidities, treatments received, and outcomes 
(appendix pp 3–4). The following criteria were used 
for CLHP programme participation: an active ARI 
programme; leadership commitment; one health worker 
responsible for implementation (local ARI coordinator); 
and about 100 000 population catchment area.6 District 
government hospitals were prioritised for participation in 
CLHP, and by 2004, 22 of 23 district hospitals and three 
of four central government hospitals were enrolled.6 In 
2005, with the support of the Scottish Government, the 
programme expanded to include the Christian Hospital 
Association of Malawi hospitals, which are mostly fi rst-
level, fee-based facilities. By 2012, 22 of 23 district 
hospitals, three of four central hospitals, and 16 of 
37 Christian Hospital Association of Malawi facilities 
were participating in the CLHP (appendix p 5).
From 2001 to 2005, major external support was provided 
to the CLHP: health staﬀ  were trained in the programme, 
which included a follow-up refresher session and on-the-
job training; international expert technical guidance that 
focused on maintaining data quality, accuracy, and 
completeness was provided twice annually; and 
Research in context
Evidence before this study
A recent systematic review identifi ed only 11 studies reporting 
data on mortality in children admitted to hospital with acute 
lower respiratory infections in the African region, and with very 
few exceptions, reports were unpublished, and with an 
observation time limited to 2–3 years. We also searched PubMed 
using the following search strategy: (“Pneumonia”[Mesh] OR 
“Respiratory Tract Infections”[Mesh]) AND (“Child”[Mesh] OR 
(“child”[MeSH Terms] OR “child”[All Fields] OR “children”[All 
Fields]) OR (“pediatrics”[MeSH Terms] OR “pediatrics”[All Fields] 
OR “paediatric”[All Fields]) OR (“pediatrics”[MeSH Terms] OR 
“pediatrics”[All Fields] OR “pediatric”[All Fields])) AND 
(“Malawi”[MeSH Terms] OR “Malawi”[All Fields]) from inception 
to July 8, 2015, with no language restrictions. We found 
68 studies, none of which covered the range of years and 
numbers of hospitals of our study.
Added value of this study
We have analysed an individual patient database of hospitalised 
cases of pneumonia in children in Malawi, collected over a 
12 year period. The data shows a clear decline in case fatality 
rate between 2001 and 2012, although this rate remains high 
in some subgroups (children with very severe pneumonia, 
severe undernutrition, severe acute malnutrition, and symptom 
duration >21 days).
Implications of all the available evidence
Overall, our study supports the fi nding from the Millennium 
Development Goal 4 indicators that under-5 mortality has 
signifi cantly decreased in Malawi in recent years. Further 
research is needed to link hospital data with community-based 
pneumonia data and to investigate quality of care provided to 
children at diﬀ erent levels of the health system.
Panel: Classifi cation of severity of clinical pneumonia10
Non-severe pneumonia (2–59 months of age)*
• Cough, diﬃ  culty breathing, or both
• Fast breathing for age†
• No lower chest indrawing and no danger signs‡
Severe pneumonia (<2 months of age)
• Cough, diﬃ  culty breathing, or both, and
• Lower chest indrawing or fast breathing for age*†
• No danger signs‡
Severe pneumonia (2–59 months of age)
• Cough, diﬃ  culty breathing, or both
• Lower chest indrawing
• No danger signs‡
• Might or might not have fast breathing for age†
Very severe pneumonia (0–59 months of age)
• Cough, diﬃ  culty breathing, or both
• At least one danger sign‡
• Might or might not have fast breathing for age†
• Lower chest indrawing
* Young infants younger than 2 months do not have a non-severe pneumonia 
classifi cation. †60 breaths per min or more if child is younger than 2 months; 50 breaths 
per min or more if child is 2–11 months old; 40 breaths per min or more if child is 
12–59 months old. ‡Danger signs are any of the following: central cyanosis, severe 
respiratory distress (grunting, head nodding, severe chest indrawing), stridor, a general 
danger sign (inability to drink, breastfeed, or both, lethargy or unconsciousness, 
convulsions), apnoea (if child is 0–2 months of age). Wheeze is not considered in 
diagnosis or classifi cation of severity of pneumonia.10
See Online for appendix
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programme managers met regularly to review their 
work.6 The CLHP also provided an uninterrupted supply 
of antibiotic drugs for pneumonia treatment.6 Between 
2006 and 2008, the programme was gradually transitioned 
to the Ministry of Health, whereas external assistance 
focused on enrolling facilities from the Christian Hospital 
Association of Malawi using previous approaches. In 
2009, the Ministry of Health assumed primary control 
and arranged supervision visits and follow-up trainings 
according to local needs and available funding.
Between November, 2012, and May, 2013, the study 
authors and data collectors employed by PACHI (the 
local research organisation conducting the study) 
collected all available hard copies of yellow forms from 
40 of the 41 participating hospitals, where the forms were 
stored (usually under the supervision of the local ARI 
coordinator). Standardised data cleaning and data entry, 
including systematic quality assurance checks, were 
done by data entry clerks and nurses under close 
supervision by ML, RB, and SS. Confi dentiality was 
maintained by de-identifying all fi les before database entry.
This study was approved by the Ethics Committee of 
University College London (project number 2006/002) and 
by the National Health Sciences Research Committee of 
Malawi (protocol number 941). 
Descriptive and statistical analyses
Our descriptive analyses focused on the following 
outcomes: annual case fatality rates, annual case fatality 
rates in predefi ned population subgroups, and changes in 
children’s characteristics with time. Young infants 
(defi ned as infants younger than 2 months) and children 
age 2–59 months were analysed separately since 
pneumonia classifi cation and treatment diﬀ ers in these 
two groups, according to WHO guidelines.8–10 Weight-for-
age was analysed according to WHO 2006 standards 
applied retrospectively to the dataset.11 WHO moderate 
undernutrition and severe undernutrition were defi ned 
as weight-for-age ranging between –3 and –2 SD from the 
median and weight-for-age less than –3 SD from the 
median, respectively. The clinical diagnosis of severe 
acute malnutrition was made prospectively during patient 
care on the basis of visible signs of wasting or oedema of 
both feet as per Malawi guidelines.8–10 Pneumonia and 
fast breathing were defi ned according to standard WHO 
criteria (panel). Fever was defi ned as body temperature 
greater than 38°C.
We compared mortality rates in patients for whom we 
had data on basic demographic variables and risk factor 
variables with rates in patients with missing data using 
the χ² statistic, Fisher’s exact test, or t test, as appropriate, 
to informally investigate the likelihood that missing data 
could substantially bias subsequent analyses. We also did 
sensitivity analyses assuming diﬀ erent probabilities of 
mortality for the cases missing data on mortality relative 
to cases with data (0, 0∙1x, 0∙5x, 2x, 10x, and 1, where x is 
the probability of mortality in cases with data).
We compared rates by year using the χ² test for trend 
(Cochrane–Armitage test). Univariable logistic regression 
was used to calculate odds ratios (ORs) for mortality 
associated with each risk factor in each age group and in 
diﬀ erent population subgroups; survival time until death 
was not recorded (appendix p 3–4), precluding Cox 
regression.
For all statistical tests, a p value of 0·05 or less 
(two-sided) was considered signifi cant. We used 
Stata version 13·1 for all analyses.12
Three multivariable logistic regression models were 
created to determine risk factors for mortality for 
pneumonia cases admitted to hospital in children younger 
than 2 months, age 2–11 months, and age 12–59 months 
separately. We used bootstrap resampling of stepwise 
backwards elimination with a p value cutoﬀ  greater than 
0∙05 for leaving the model to build multivariable models 
for each age group.13,14 All variables except HIV and malaria 
(risk factors for which too much data were missing) were 
initially entered into each of 100 bootstrap replications, 
and variables that were selected in more than 50% of the 
replications were included in the fi nal models.13,14 As 
pneumonia cases were included from 40 hospitals, 
mortality could be correlated within hospitals. Likelihood 
ratio test confi rmed the clustered nature of the data, and 
we used mixed eﬀ ects logistic regression models to 
account for this. Results of the multivariable logistic 
regression analyses are presented as adjusted OR (AOR) 
with 95% CI. Events per variable15 and area under the 
receiver-operator-characteristic (ROC) curve are presented 
as measures of model adequacy and goodness of fi t.
To reduce bias and loss of information due to missing 
data, we used multiple imputation with the assumption 
that data was missing at random. Data showed evidence 
of clustering, so we used REALCOM impute software to 
impute missing data.16 Variables in the multiple 
imputation models included the mortality outcome, risk 
Figure 1: Study fl ow diagram
115 240 cases of pneumonia in the database
113 154 available for analysis
104 932 cases for which data are available for 
the analysis of mortality
2086 ineligible
672 duplicates
565 older than 5 years
598 age unknown
251 date of admission unknown or not 
during 2001–12
8222 excluded
7741 data on final outcome missing
481 treatment failure
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Younger than 2 months (n=10 860) 2–59 months (n=102 294) Total (%) n=113 154
Survived (%) n=9247 Died (%) n=712 Missing (%) n=901 Survived (%) n=88 782 Died (%) n=6191 Missing (%) n=7321
Region of Malawi
Northern 1641 (18%) 128 (18%) 104 (12%) 16 914 (19%) 1059 (17%) 1101 (15%) 20 947 (19%)
Central 4098 (44%) 334 (65%) 480 (53%) 38 247 (43%) 2456 (40%) 3166 (43%) 48 781 (43%)
Southern 3508 (38%) 250 (35%) 316 (35%) 33 612 (38%) 2676 (43%) 3053 (42%) 43 415 (38%)
Missing 0 0 1 (<1%) 9 (<1%) 0 1 (<1%) 11 (<1%)
Type of facility
District 7250 (78%) 556 (78%) 616 (68%) 71 089 (80%) 4993 (81%) 4710 (64%) 89 214 (79%)
Central 888 (10%) 79 (11%) 61 (7%) 7978 (9%) 554 (9%) 639 (9%) 10 199 (9%)
Mission or rural 1109 (12%) 77 (11%) 223 (25%) 9706 (11%) 644 (10%) 1971 (27%) 13 730 (12%)
Missing 0 0 1 (<1%) 9 (<1%) 0 1 (<1%) 11 (<1%)
Sex
Female 3880 (42%) 303 (43%) 380 (42%) 38 858 (44%) 3097 (50%) 3933 (54%) 49 639 (44%)
Male 5109 (55%) 386 (54%) 475 (53%) 48 128 (54%) 2947 (48%) 3121 (43%) 60 978 (54%)
Missing 258 (3%) 23 (3%) 46 (5%) 1796 (2%) 147 (2%) 267 (4%) 2537 (2%)
Severity of pneumonia in children age 2–59 months
Very severe N/A N/A N/A 19 186 (22%) 3804 (61%) 1916 (26%) 24 906 (24%)
Severe N/A N/A N/A 66 872 (75%) 2206 (36%) 4904 (67%) 73 982 (72%)
Non-severe N/A N/A N/A 1581 (2%) 46 (1%) 273 (4%) 1900 (2%)
Pneumocystis jirovecii N/A N/A N/A 169 (<1%) 74 (1%) 36 (1%) 279 (<1%)
Other N/A N/A N/A 65 (<1%) 2 (<1%) 0 68 (<1%)
Missing N/A N/A N/A 909 (1%) 58 (1%) 192 (3%) 1159 (1%)
Severity of pneumonia in infants <2 months
Very severe 4082 (44%) 528 (74%) 338 (38%) N/A N/A N/A 4948 (46%)
Severe 5010 (54%) 165 (23%) 506 (56%) N/A N/A N/A 5681 (52%)
Pneumocystis jirovecii 15 (<1%) 3 (<1%) 5 (1%) N/A N/A N/A 23 (<1%)
Other 3 (<1%) 0 0 N/A N/A N/A 3 (<1%)
Missing 137 (2%) 16 (2%) 52 (6%) N/A N/A N/A 205 (2%)
Days with symptoms (before admission)
<21 days 8234 (89%) 637 (90%) 781 (87%) 79 003 (89%) 5260 (85%) 6284 (86%) 100 199 (89%)
>21 days 167 (2%) 14 (2%) 17 (2%) 2284 (3%) 336 (5%) 255 (4%) 3073 (3%)
Missing 846 (9%) 61 (9%) 103 (11%) 7495 (8%) 595 (10%) 782 (11%) 9882 (9%)
Antibiotic treatment prior to hospital attendance
No 4844 (52%) 359 (50%) 438 (49%) 43 805 (49%) 2534 (41%) 3213 (44%) 55 193 (49%)
Yes 2090 (23%) 175 (25%) 203 (23%) 23 040 (26%) 2080 (34%) 1934 (26%) 29 522 (26%)
Missing 2313 (25%) 178 (25%) 260 (29%) 21 937 (25%) 1577 (26%) 2174 (30%) 28 439 (25%)
Referral type
Self-referral 6037 (65%) 365 (51%) 516 (57%) 59 626 (67%) 3157 (51%) 4309 (59%) 74 010 (65%)
Referral by health centre 1959 (21%) 241 (34%) 222 (25%) 17 380 (20%) 2088 (34%) 1728 (24%) 23 618 (21%)
Missing 1251 (14%) 106 (15%) 163 (18%) 11 776 (13%) 946 (15%) 1284 (18%) 15 526 (14%)
Pneumonia in past 12 months
No 8262 (89%) 623 (88%) 748 (83%) 66 047 (74%) 4612 (75%) 4991 (68%) 85 283 (75%)
Yes 223 (2%) 16 (2%) 25 (3%) 16 481 (19%) 1024 (17%) 1278 (18%) 19 047 (17%)
Missing 762 (8%) 73 (10%) 128 (14%) 6254 (7%) 555 (9%) 1052 (14%) 8824 (8%)
Previous hospital admission for pneumonia in past 12 months
No 8333 (90%) 622 (87%) 754 (84%) 71 541 (81%) 4944 (80%) 5390 (74%) 91 584 (81%)
Yes 128 (1%) 13 (2%) 10 (1%) 10 777 (12%) 660 (11%) 816 (11%) 12 404 (11%)
Missing 786 (9%) 77 (11%) 137 (15%) 6464 (7%) 587 (10%) 1115 (15%) 9166 (8%)
Measles in past 2 months
No 7914 (86%) 596 (84%) 681 (76%) 74 872 (84%) 5068 (82%) 5321 (73%) 94 452 (84%)
Yes 25 (<1%) 0 3 (<1%) 1182 (1%) 91 (2%) 121 (2%) 1422 (1%)
Missing 1308 (14%) 116 (16%) 217 (24%) 12 728 (14%) 1032 (17%) 1879 (26%) 17 280 (15%)
(Table 1 continues on next page)
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Younger than 2 months (n=10 860) 2–59 months (n=102 294) Total (%) n=113 154
Survived (%) n=9247 Died (%) n=712 Missing (%) n=901 Survived (%) n=88 782 Died (%) n=6191 Missing (%) n=7321
(Continued from next page)
Weight for age category
Normal 7868 (85%) 472 (66%) 702 (78%) 64 641 (73%) 2765 (45%) 4784 (65%) 81 232 (72%)
Moderate underweight* 570 (6%) 107 (15%) 75 (8%) 11 939 (13%) 1208 (20%) 1028 (14%) 14 927 (13%)
Severe underweight* 248 (3%) 58 (8%) 23 (3%) 7097 (8%) 1338 (22%) 740 (10%) 9504 (8%)
Missing 561 (6%) 75 (11%) 101 (11%) 5105 (6%) 880 (14%) 769 (11%) 7491 (7%)
Severe acute malnutrition†
Absent 7892 (85%) 578 (81%) 675 (75%) 74 570 (84%) 4649 (75%) 5269 (72%) 93 633 (83%)
Present 21 (<1%) 6 (1%) 5 (1%) 1047 (1%) 482 (8%) 151 (2%) 1712 (2%)
Missing 1334 (14%) 128 (18%) 221 (25%) 13 165 (15%) 1060 (17%) 1901 (26%) 17 809 (16%)
Temperature
Afebrile 6488 (70%) 445 (63%) 604 (67%) 47 949 (54%) 3400 (55%) 3714 (51%) 62 600 (55%)
Febrile (>38°C) 1355 (15%) 143 (20%) 113 (13%) 27 105 (31%) 1699 (27%) 2139 (29%) 32 554 (29%)
Missing 1404 (15%) 124 (17%) 184 (20%) 13 728 (16%) 1092 (18%) 1468 (20%) 18 000 (16%)
Mean (SD, range), °C 37·3
(0·9, 30·0–42·2)
37·2
(1·5, 31·0–42·0)
37·3
(0·9, 33·5–41·1)
37·8
(1·2, 30·0–45·0)
37·7
(1·2, 30·7–42·0)
37·8
(1·2, 30·2–42·0)
37·8
(1·2, 30·0–45·0)
Median, °C (IQR) 37·2
(36·8–38·0)
37·2
(36·8–38·0)
37·1
(36·7–38·0)
37·8
(37·0–38·7)
37·8
(37·0–38·5)
37·8
(37·0–38·7)
37·8
(37·0–38·6)
Season
Dry (May–October) 4206 (46%) 385 (54%) 439 (49%) 42 675 (48%) 3046 (49%) 3735 (51%) 54 486 (48%)
Wet (November–April) 5019 (54%) 326 (46%) 455 (51%) 45 925 (52%) 3124 (51) 3543 (48%) 58 392 (52%)
Missing 22 (<1%) 1 (<1%) 7 (1%) 182 (<1%) 21 (<1%) 43 (1%) 276 (<1%)
Respiratory rate
Normal 1362 (15%) 83 (12%) 184 (20%) 4523 (5%) 364 (6%) 467 (6%) 6983 (6%)
Fast breathing‡ 6903 (75%) 543 (76%) 543 (60%) 75 674 (85%) 5139 (83%) 5534 (76%) 94 336 (83%)
Missing 982 (11%) 86 (12%) 174 (19%) 8585 (10%) 688 (11%) 1320 (18%) 11 835 (11%)
Mean (SD, range) 67 (12·7, 2–198) 69 (14·2, 20–155) 65 (13·6, 2–180) 61 (12·3, 2–270) 64 (14·3, 5–180) 60 (13·3, 3–195) 62 (12·7, 2–270)
Median (IQR) 66 (61–72) 68 (62–75) 64 (59–70) 60 (54–68) 62 (56–70) 60 (52–67) 60 (54–68)
Malaria blood fi lm status
Negative 1103 (12%) 50 (7%) 79 (9%) 16 196 (18%) 974 (16%) 968 (13%) 19 370 (17%)
Positive 266 (3%) 17 (2%) 18 (2%) 7708 (9%) 562 (9%) 490 (7%) 9061 (8%)
Missing 7878 (85%) 645 (91%) 804 (89%) 64 878 (73%) 4655 (75%) 5863 (80%) 84 723 (75%)
HIV status
Negative 643 (7%) 34 (5%) 68 (8%) 5441 (6%) 292 (5%) 448 (6%) 6926 (6%)
Positive 68 (1%) 7 (1%) 7 (1%) 1248 (1%) 241 (4%) 151 (2%) 1722 (2%)
Missing 8536 (92%) 671 (94%) 826 (92%) 82 093 (93%) 5658 (91%) 6722 (92%) 104 506 (92%)
Outcome§
Died within 24 h of 
admission
0 404 (57%) 0 0 2966 (48%) 0 3370 (3%)
Died after 24 h of 
admission
0 308 (43%) 0 0 3225 (52%) 0 3533 (3%)
Left against advice 389 (4%) 0 0 2585 (3%) 0 0 2974 (3%)
Transferred 31 (<1%) 0 0 373 (<1%) 0 0 404 (<1%)
Discharged alive 8827 (96%) 0 0 85 824 (97%) 0 0 94 651 (84%)
Treatment failure at 48 h 0 0 5 (1%) 0 0 310 (4%) 315 (<1%)
Treatment failure at day 5 0 0 6 (1%) 0 0 160 (2%) 166 (<1%)
Missing 0 0 890 (99%) 0 0 6851 (94%) 7741 (7%)
Data are n (%) unless otherwise indicated. N/A=not appropriate. *Moderate undernutrition was defi ned as weight-for-age less than –2 SD from the mean based on the WHO 2006 growth reference standards; 
severe undernutrition was defi ned as weight-for-age less than –3 SD based on the WHO 2006 growth reference standards·10 †The diagnosis of severe acute malnutrition was made prospectively during patient care 
by the health worker based on visible signs of severe wasting or oedema of both feet or by National Guidelines in Malawi·8,10 ‡60 breaths per min of more if <2 months old, ≥50 breaths per min if 2–11 months old; 
40 breaths per min or more if 12–59 months old. §Left against advice and Transferred are counted as Survived as the child did not die in the facility and we are only able to measure deaths in the facility (ie, calculate 
facility case fatality rate rather than population-level mortality). However, treatment failures are counted as missing for mortality as they are more likely to have died (although we do not have any data on this).
Table 1: Study population characteristics
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factors of mortality included in the multivariable models, 
and key variables that were found to be predictors of 
missingness including region and type of facility. The 
HIV and malaria variables were excluded for having too 
many missing data to be imputed. Once we imputed the 
data in REALCOM, the data were uploaded into Stata for 
analysis using the commands “mi estimate: xtmelogit”.12
We used separate logistic regression models to analyse 
the available data for HIV. Scenarios were generated to 
assess the eﬀ ect of possible trends of HIV prevalence 
and case fatality rates in HIV-negative cases on overall 
case fatality rates, assuming odds of mortality in 
HIV-positive pneumonia cases 5∙9 times higher than the 
odds of mortality in HIV-negative cases17 in fi ve scenarios 
and changing the odds in another scenario.
Role of the funding source
The funder of the study had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding authors had full 
access to all the data in the study and had fi nal 
responsibility for the decision to submit for publication.
Results
All clinical pneumonia cases registered on the yellow 
forms with an age younger than 5 years were included 
(fi gure 1). Of the 113 154 unique cases within the dataset 
that were available for analysis (fi gure 1), 102 294 cases 
were aged 2–59 months and 10 860 cases were younger 
than 2 months. The number of cases with each potential 
risk factor in young infants and children who survived, 
died, or for whom data on case fatality were missing are 
listed in table 1. Overall, less than 20% of data were 
missing for all but three variables: previous antibiotic 
treatment (25·1% of data were missing), malaria blood 
fi lm (74·8% of data were missing), and HIV status 
(92·3% of data were missing). The number of annual 
cases can be found in the appendix (p 6). District 
hospitals contributed the largest number of cases 
(appendix p 7).
6903 deaths were registered between 2001 and 2012, an 
overall case fatality rate of 6·6% (95% CI 6·4–6·7). The 
case fatality rate decreased with time (15·2% [13·4–17·1] 
in 2001 vs 4·5% [4·1–4·9] in 2012; ptrend<0·0001; fi gure 2), 
even when mortality was assumed to be ten times higher 
in cases for whom mortality data were missing than in 
cases with mortality data.
In the multivariable model, the following risk factors 
were signifi cantly associated with high mortality in 
infants younger than 2 months (table 2): very severe 
pneumonia (compared with severe pneumonia); referral 
from a health centre (compared with self-referral); 
moderately underweight and severely underweight for 
age (compared with normal weight for age); and febrile 
temperature (compared with afebrile temperature). 
Wet season (compared with dry season), increasing year 
from 2001 to 2012, and increasing age (1 month of age 
compared with 0 months of age) were associated with 
lower mortality. Severe acute malnutrition, which was 
signifi cantly associated with higher mortality, was the 
only signifi cant variable in univariable analyses that was 
not included in the multivariable model.
In children aged 2–11 months, our fi ndings were 
similar to those of young infants with respect to the 
above-cited risk factors (table 2). The following risk 
factors were also signifi cantly associated with increased 
odds of mortality: location of hospital in the 
southern region; female sex; clinically suspected 
Pneumocystis jirovecii infection; more than 21 days with 
symptoms; and severe acute malnutrition. Fast breathing 
(compared with normal breathing) was the only 
additional factor associated with lower mortality in the 
multivariable model. Previous antibiotic treatment, 
Figure 2: (A) Case fatality rate for children with pneumonia in Malawi (missing data not included) and 
(B) worst and best case scenario case fatality rates on the basis of diﬀ erent assumptions about case fatality 
for cases with missing data on fatality, 2001–12
Error bars show 95% CI.
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Younger than 2 months 2–11 months 12–59 months
Univariable analyses OR 
(95% CI)
Multivariable model 
n=6878¶|| AOR (95% CI)
Univariable analyses OR 
(95% CI)
Multivariable model 
n=34 427¶** AOR (95% CI)
Univariable analyses 
OR (95% CI)
Multivariable model 
n=28 952¶†† AOR 
(95% CI)
Geographical region of Malawi
Northern 1·00 ·· 1·00 1·00 1·00 ··
Central 1·00 (0·70–1·43) ·· 1·00 (0·75–1·32) 1·10 (0·85–1·44) 1·21 (0·85–1·70) ··
Southern 0·94 (0·66–1·35) ·· 1·50 (1·13–1·98) 1·42 (1·09–1·84) 1·37 (0·97–1·94) ··
Type of health-care facility
District 1·00 ·· 1·00 ·· 1·00 ··
Central 1·05 (0·75–1·47) ·· 1·23 (0·94–1·60) ·· 1·05 (0·78–1·42) ··
Mission/rural 1·13 (0·67–1·92) ·· 1·34 (0·84–2·13) ·· 0·77 (0·46–1·30) ··
Sex
Male 1·00 ·· 1·00 1·00 1·00 1·00
Female 1·04 (0·89–1·22) ·· 1·32 (1·24–1·41) 1·51 (1·38–1·65) 1·27 (1·16–1·41) 1·35 (1·18–1·54)
Pneumonia classifi cation‡
Non-severe N/A N/A 1·00 1·00 1·00 1·00
Severe 1·00 1·00 1·56 (1·01–2·43) 2·20 (1·02–4·71) 0·73 (0·48–1·09) 1·60 (0·74–3·43)
Very severe 4·11 (3·42–4·95) 3·60 (2·81–4·60) 9·44 (6·10–14·62) 12·22 (5·70–26·17) 4·30 (2·86–6·44) 9·38 (4·37–20·09)
Pneumocystis jirovecii 5·47 (1·55–19·33) 5·80 (0·71–47·38) 19·93 (11·72–33·89) 21·35 (8·86–51·46) 5·26 (2·25–12·30) 6·25 (1·62–24·05)
Days with symptoms
<21 days 1·00 ·· 1·00 1·00 1·00 ··
>21 days 1·10 (0·63–1·92) ·· 1·99 (1·72–2·29) 1·35 (1·08–1·67) 2·36 (1·90–2·92) ··
Previous antibiotic treatment
No 1·00 ·· 1·00 ·· 1·00
Yes 1·14 (0·94–1·38) ·· 1·48 (1·38–1·59) ·· 1·66 (1·48–1·86) ··
Type of referral
Self-referral 1·00 1·00 1·00 1·00 1·00 1·00
From health centre 2·02 (1·70–2·41) 1·85 (1·50–2·29) 2·02 (1·88–2·17) 1·72 (1·56–1·88) 2·85 (2·55–3·18) 2·23 (1·94–2·57)
Previous pneumonia in past 12 months
No 1·00 ·· 1·00 ·· 1·00 ··
Yes 0·96 (0·58–1·62) ·· 1·09 (1·00–1·19) ·· 0·86 (0·76–0·98) ··
Previous hospital admission due to pneumonia
No 1·00 ·· 1·00 ·· 1·00 ··
Yes 1·39 (0·78, 2·48) ·· 1·17 (1·05–1·30) ·· 0·83 (0·72–0·96) ··
Measles in past 2 months
No * ·· 1·00 1·00 1·00 ··
Yes * ·· 1·19 (0·93–1·52) 1·31 (0·92–1·87) 0·87 (0·55–1·37) ··
Weight for age
Normal weight 1·00 1·00 1·00 1·00 1·00 1·00
Moderately underweight 3·20 (2·55–4·03) 3·37 (2·54–4·47) 2·60 (2·39–2·82) 2·27 (2·04–2·53) 2·07 (1·80–2·37) 1·70 (1·43–2·02)
Severely underweight 3·82 (2·82–5·18) 3·76 (2·56–5·53) 4·24 (3·89–4·62) 3·42 (3·04–3·85) 5·00 (4·40–5·68) 3·23 (2·72–3·84)
Severe acute malnutrition
Absent 1·00 ·· 1·00 1·00 1·00 1·00
Present 3·91 (1·55, 9·86) ·· 6·62 (5·63–7·79) 2·85 (2·18–3·75) 10·04 (8·51–11·84) 4·19 (3·28–5·35)
Malaria blood fi lm positive
No 1·00 † 1·00 † 1·00 †
Yes 1·47 (0·82–2·65) † 1·03 (0·90–1·18) † 1·52 (1·27–1·83) †
HIV status
Negative 1·00 † 1·00 † 1·00 †
Positive 1·95 (0·83–4·56) † 3·93 (3·11–4·96) † 3·43 (2·51–4·69) †
Body temperature
Afebrile 1·00 1·00 1·00 ·· 1·00 ··
Febrile (>38°C) 1·56 (1·28–1·91) 1·52 (1·20–1·93) 0·94 (0·87–1·01) ·· 0·83 (0·75–0·93) ··
(Table 2 continues on next page)
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previous hospital admission with pneumonia, and HIV-
positive status were signifi cantly associated with 
increased mortality in univariable analyses but not 
included in the multivariable model.
Findings in children aged 12–59 months were similar 
to those in children age 2–11 months, although region, 
number of days with symptoms, measles in the past 
2 months, and respiratory category were not in the 
multivariable model whereas season was, with wet 
season signifi cantly associated with higher mortality 
(table 2).
Results from the multiple imputation models 
indicated that missing data had little eﬀ ect on the 
estimates from the complete case analysis. Only the 
association of clinically diagnosed P jirovecii with 
mortality in children younger than 2 months was 
statistically signifi cant with multiple imputation, 
whereas this risk factor was not statistically signifi cant 
without multiple imputation (appendix p 22 and 
table 2).
Between 2001 and 2012, the proportion of children with 
characteristics associated with a higher odds of mortality 
decreased; these characteristics included very severe 
pneumonia of any age group, children 2–59 months old 
with moderate and severe underweight for age, and 
children receiving antibiotics before admission to 
hospital (table 3). During this period, the proportion of 
children with characteristics associated with lower odds 
of death (children diagnosed or admitted to hospital with 
pneumonia in the past year) increased.
Overall, we found the same decreasing trend in 
mortality when cases where stratifi ed by age, region, 
hospital type, sex, pneumonia severity, weight-for-age, 
duration of illness, type of access to hospital, previous 
treatment, prior history of pneumonia or hospital 
admission, and HIV status (table 4, appendix pp 8–21).
Despite this progress, case fatality rates in 2012 remained 
high for children of all ages with very severe pneumonia 
(11·8%; 10·3% for infants younger than 2 months, 16·5% 
for infants aged 2–11 months, and 6·1% for children aged 
12–59 months), severe undernutrition (15·4%), and severe 
acute malnutrition (34·8%), and for children with 
symptoms lasting more than 21 days (9·0%; ).
The additional logistic regression model used with the 
available HIV data showed that the reduction in 
pneumonia mortality per year was statistically 
signifi cant even if HIV status was included in the model 
(AOR of mortality per year 0∙89 [95% CI 0∙85–0∙93], 
p<0∙0001, n=7842). When using the conservative 
assumption that all cases missing HIV data were HIV-
negative, this result remains signifi cant (AOR of 
mortality per year 0∙883 [0∙875–0∙892], p<0∙0001, 
n=103 184).
The possible eﬀ ects on pneumonia case fatality rates of 
changes in HIV prevalence with time are shown in the 
appendix (p 30). None of the scenarios supported the 
hypothesis that the decrease in pneumonia case fatality 
rate can predominantly be explained by a decrease in 
HIV prevalence.
Discussion
Our study shows that overall mortality for children 
admitted to hospital with pneumonia in Malawi has 
signifi cantly decreased between 2001 and 2012. The 
decrease in case fatality rate was gradual and consistent 
across regions, hospital types, sex, age, pneumonia 
severity, type of access to hospital, type of previous 
treatment, and previous history of pneumonia or hospital 
Younger than 2 months 2–11 months 12–59 months
Univariable analyses OR 
(95% CI)
Multivariable model 
n=6878¶|| AOR (95% CI)
Univariable analyses OR 
(95% CI)
Multivariable model 
n=34 427¶** AOR (95% CI)
Univariable analyses 
OR (95% CI)
Multivariable model 
n=28 952¶†† AOR 
(95% CI)
(Continued from previous page)
Season
Dry (May–October) 1·00 1·00 1·00 ·· 1·00 1·00
Wet (November–April) 0·71 (0·60–0·82) 0·72 (0·59–0·88) 0·90 (0·85–0·96) ·· 1·08 (0·98–1·20) 1·57 (1·01–1·32)
Respiratory category
Normal 1·00 ·· 1·00 1·00 1·00 ··
Fast breathing§ 1·27 (1·00–1·61) ·· 1·05 (0·93–1·18) 0·80 (0·67–0·95) 0·79 (0·59–1·06) ··
Year admitted to hospital 
per year, 2001–12
0·886 (0·861–0·911) 0·909 (0·876–0·944) 0·888 (0·878–0·898) 0·915 (0·900–0·929) 0·885 (0·870, 0·901) 0·915 (0·893–0·938)
Age, months 0·563 (0·480–0·660) 0·567 (0·458–0·703) 0·954 (0·943–0·965) 0·947 (0·932 – 0·963) 0·991 (0·986, 0·996) ··
OR=odds ratio. AOR=adjusted odds ratio. ··=data not included in fi nal multivariable model. N/A=not applicable. *Model did not converge because none of the cases that died had measles (and only 25 cases of 
measles in total). †Not entered into multivariable model building process as too much missing data. ‡See panel for defi nitions. §More than 60 breaths per min for children younger than 2 months; 50 breaths per 
min or more for children 2–11 months old; and 40 breaths per min for children 12–59 months old. ¶Number of cases in multivariable model are less than total number of cases because of missing data for one or 
more variables in the model. ||445 deaths; nine variables; 49 events per variable; area under ROC curve 0·77. **2520 deaths, 15 variables, 168 events per variable; area under ROC curve 0·81. ††1004 deaths; ten 
variables, 100 events per variable; area under ROC curve 0·83.
Table 2: Univariable analyses and mixed eﬀ ects multivariable regression analysis showing odds ratio (95% CI) for risk factors for mortality in children younger than 2 months, 
2–11 months of age, and 12–59 months of age
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admission. Furthermore, the association of decreasing 
case fatality rate by study year was statistically signifi cant 
in our multivariable models for each age group. In 
parallel, the prevalence of mortality risk factors (very 
severe pneumonia and malnutrition) decreased, and the 
prevalence of potentially protective factors increased. 
Despite this progress, we saw no signifi cant decrease in 
mortality for some categories of children, such as 
Year of study Slope (SE); ptrend
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Female sex 674 
(44∧3%; 
41∧9–
46∧9)
1516 
(47∧4%; 
45∧7–
49∧1)
2334 
(47∧7%; 
46∧3–
49∧1)
1877 
(46∧0%; 
44∧5–
47∧5)
3449 
(45∧4%; 
44∧3–
46∧5)
3493 
(44∧7%; 
43∧6–
45∧8)
4758 
(46∧2%; 
45∧2–
47∧1)
4268 
(44∧9%; 
43∧9–
45∧9)
6522 
(45∧4%; 
44∧7–
46∧3)
6907 
(43∧5%; 
42∧8–
44∧3)
7878 
(44∧2%; 
43∧5–
44∧9)
5131 
(43∧5%; 
42∧6–
44∧4)
–0∧3% (0∧1%); p<0∧0001
Young infants 
(<2 months)
110 
(7∧2%; 
6∧0–
8∧6)
230 
(7∧2%; 
6∧3–
8∧1)
514 
(10∧4%; 
9∧6–
11∧3)
371 
(9∧0%; 
8∧8–
10∧1)
735 
(9∧5%; 
8∧8–
10∧1)
946 
(11∧8%; 
11∧2–
12∧6)
1388 
(13∧1%; 
12∧5–
13∧8)
817 
(8∧4%; 
7∧9–
9∧0)
1591 
(10∧8%; 
10∧3–
11∧3)
1331 
(8∧2%; 
7∧8–
8∧6)
1675 
(9∧2%; 
8∧8–
9∧6)
930 
(7∧7%; 
7∧3–
8∧2)
–0∧1% (0∧03%); p<0∧0001
Very severe pneumonia
Age 2–59 months 431 
(30∧7%; 
28∧4–
33∧2)
989 
(33∧5%; 
31∧8–
35∧3)
1281 
(29∧2%; 
27∧9–
30∧5)
1054 
(28∧4%; 
27∧0–
29∧9)
1981 
(28∧4%; 
27∧4–
29∧5)
1863 
(26∧7%; 
25∧7–
27∧8)
2415 
(26∧6%; 
25∧7–
27∧6)
2266 
(25∧9%; 
25∧0–
26∧8)
3143 
(24∧2%; 
23∧5–
24∧9)
3095 
(21∧0%; 
20∧3–
21∧6)
3348 
(20∧4%; 
19∧8–
21∧0)
2604 
(23∧7%; 
22∧9–
24∧5)
–1∧0% (0∧1%); p<0∧0001
Age <2 months 77 
(70∧6%; 
61∧4–
78∧5)
158 
(70∧9%; 
64∧5–
76∧5)
295 
(57∧8%; 
53∧5–
62∧1)
195 
(53∧4%; 
48∧3–
58∧5)
413 
(57∧7%; 
54∧0–
61∧3)
478 
(51∧3%; 
48∧1–
54∧5)
691 
(50∧8%; 
(48∧1–
53∧4)
410 
(50∧7%; 
47∧2–
54∧1)
687 
(43∧6%; 
41∧2–
46∧1)
492 
(37∧8%; 
35∧2–
40∧5)
613 
(37∧4%; 
35∧1–
39∧8)
340 
(37∧4%; 
34∧4–
40∧6)
–2∧9% (0∧2%); p<0∧0001
Weight-for-age
Moderately 
underweight*
264 
(17∧4%; 
15∧5–
19∧3)
610 
(19∧0%; 
17∧6–
19∧3)
810 
(16∧5%; 
15∧4–
17∧5)
680 
(16∧5%; 
15∧4–
17∧7)
1142 
(14∧7%; 
13∧9–
15∧5)
1148 
(14∧4%; 
13∧6–
15∧2)
1414 
(13∧3%; 
12∧7–
14∧0)
1314 
(13∧6%; 
12∧9–
14∧3)
1850 
(12∧6%; 
12∧1–
13∧1)
1994 
(12∧3%; 
11∧8–
12∧8)
2068 
(11∧3%; 
10∧9–
11∧8)
1400 
(11∧6%; 
11·1–
12·2)
–0∧6% (0∧03% <0∧0001
Severely 
underweight*
182 
(12∧0%; 
10∧4–
13∧7)
458 
(14∧2%; 
13∧1–
15∧5)
573 
(11∧6%; 
10∧8–
12∧6)
503 
(12∧2%; 
11∧2–
13∧2)
863 
(11∧1%; 
10∧4–
11∧8)
838 
(10∧5%; 
9∧8–
11∧2)
915 
(8∧6%; 
8∧1–
9∧2)
872 
(9∧0%; 
8∧4–
9∧6)
1162 
(7∧9%; 
7·5–
8·4)
1119 
(6∧9%; 
6·5–
7·3)
1131 
(6∧2%; 
5·8–
6·5)
727 
(6∧0%; 
5·6–
6·5)
–0∧7% (0∧03%); <0∧0001
Severe acute 
malnutrition†
70 
(5∧2%; 
4·2–6·6)
187 
(6∧1%; 
5·3–7·0)
174 
(3∧8%; 
3·2–4·3)
90 
(2∧4%; 
2·0–3·0)
152 
(2∧2%; 
1·9–2·6)
128 
(1∧8%; 
1·5–2·1)
198 
(2∧1%; 
1·9–2·5)
137 
(1∧6%; 
1·4–1·9)
193 
(1∧5%; 
1·3–1·8)
166 
(1∧3%; 
1·1–1·5)
116 
(0∧8%; 
0·7–0·9)
75
(0·8%; 
0·6–1·0)
–0∧3% (0∧02%) <0∧0001
Symptoms for >21 days 44 
(3∧0%; 
2·2–4·0)
70 
(2∧2%; 
1·8–2·8)
125 
(2∧7%; 
2·3–3·2)
150 
(3∧9%; 
3·3–4·6)
291 
(4∧1%; 
3·7–4·6)
248 
(3∧4%; 
3·0–3·8)
341 
(3∧5%; 
3·2–3·9)
327 
(3∧6%; 
3·3–4·1)
414 
(3∧0%; 
2·8–3·3)
381 
(2∧6%; 
2·3–2·8)
336 
(2∧1%; 
1·8–2·3)
282 
(2∧6%; 
2·3–2·9)
–0∧1% (0∧02%); <0∧0001
Self-referral to hospital 1134 
(77∧8%; 
75·6–
79·9)
2429 
(78∧9%; 
77·5–
80·3)
3390 
(76∧0%; 
74·7–
77·2)
2725 
(73∧5%; 
72·0–
74·9)
5145 
(75∧4%; 
74·4–
76·4)
5194 
(73∧6%; 
72·5–
74·6)
6770 
(73∧1%; 
72·2–
74·0)
6279 
(75∧2%; 
74·2–
76·1)
9822 
(76∧1%; 
75·4–
76·9)
10 506 
(75∧7%; 
74·9–
76·4)
11 787 
(76∧8%; 
76·1–
77·4)
7970 
(7∧89%; 
78·1–
79·7)
–0∧2% (0∧05%); <0∧0001
No antibiotic before 
hospital admission
1022 
(73∧5%; 
71·1–
75·8)
2103 
(75∧4%; 
73·7–
76·9)
2818 
(69∧5%; 
68·1–
70·9)
2187 
(67∧1%; 
65·5–
68·7)
4240 
(68∧3%; 
67·2–
69·5)
3765 
(61∧8%; 
60·3–
62·8)
5035 
(62∧6%; 
61·6–
63·7)
4722 
(65∧5%; 
64·4–
66·6)
7358 
(64∧5%; 
63·6–
65·3)
7637 
(63∧6%; 
62·7–
64·5)
8020 
(63∧0%; 
62·2–
63·9)
5730 
(66∧6%; 
65·6–
67·6)
-0∧6% (0∧1%); <0∧0001
Pneumonia in past 
12 months
238 
(15∧8%; 
14·1–
17·8)
498 
(15∧6%; 
14·4–
16·9)
655 
(13∧8%; 
12·8–
14·8)
657 
(16∧7%; 
15·6–
17·9)
1372 
(19∧2%; 
18·3–
20·1)
1248 
(16∧2%; 
15·4–
17·0)
1700 
(17∧1%; 
16·4–
17·9)
1749 
(19∧1%; 
18·3–
19·9)
2372 
(17∧3%; 
16·6–
17·9)
2757 
(18∧6%; 
(18·0–
19·3)
3253 
(20∧2%; 
19·6–
20·8)
2278 
(21∧0%; 
20·2–
21·8)
0∧5% (0∧04%); <0∧0001
Hospital admission in 
past 12 months
135 
(9∧0%; 
7·6–
10·5)
302 
(9∧5%; 
8·5–
10·6)
387 
(8∧2%; 
7·4–
9·0)
408 
(10∧4%; 
9·5–
11·4)
872 
(12∧2%; 
11·5–
13·0)
882 
(11∧5%; 
10·8–
12·2)
1128 
(11∧4%; 
10·8–
12·0)
1172 
(12∧8%; 
12·2–
13·5)
1532 
(11∧2%; 
10·7–
11·7)
1575 
(10∧7%; 
10·2–
11·2)
2268 
(14∧1%; 
13·6–
14·7)
1557 
(14∧3%; 
13·7–
15·0)
0∧4% (0∧04%); <0∧0001
Measles in past 
2 months
11 
(0∧8%; 
0·4–1·4)
17 
(0∧6%; 
0·3–0·9)
18 
(0∧4%; 
0·2–0·6)
13 
(0∧4%; 
(0·2–0·6)
34 
(0∧5%; 
(0·3–0·7)
43 
(0∧6%; 
0·4–0·8)
57 
(0∧6%; 
0·5–0·8)
71 
(0∧8%)
(0·7–1·0)
125 
(1∧0%; 
0·8–1·2)
749 
(5∧7%; 
5·3–6·1)
186 
(1∧3%; 
1·1–1·5)
70 
(0∧7%; 
0·6–0·9)
0∧2% (0∧01%); <0∧0001
Data are n (%; 95% CI of the proportion). Only variables with less than 20% missing data are included in the analysis, with the exception of antibiotic treatment before hospital admission (rate of missing data 
25%); ptrend was calculated for 2001–12. *Moderate undernutrition was defi ned as weight-for-age less than –2 SD from the mean based on the WHO 2006 growth reference standards; severe undernutrition was 
defi ned as weight-for-age less than –3 SD based on the WHO 2006 growth reference standards·10 †The diagnosis of severe acute malnutrition was made prospectively during patient care by the health worker based 
on visible signs of severe wasting or oedema of both feet or by National Guidelines in Malawi·8,10
 Table 3: Percentage of children presenting with possible factors aﬀ ecting the risk of pneumonia mortality, by study year
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children with very severe pneumonia, severe under-
nutrition, severe acute malnutrition, and symptoms 
lasting more than 21 days. Our fi ndings also suggest 
possible sex inequality (girls had higher case fatality rates 
than boys) and regional disparities (southern Malawi 
with a higher mortality than other regions).
Several factors might have aﬀ ected our results. The 
retrospective nature of this study might have biased 
results in several ways. First, variables were limited to 
those routinely collected on the yellow form whereas 
information on other potentially important factors such as 
vaccination status and socioeconomic condition, or height 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Region
Northern 92 (17%) 75 (11%) 88 (9%) 102 (10%) 137 (8%) 132 (7%) 123 (6%) 90 (5%) 127 (5%) 84 (4%) 72 (3%) 45 (3%)
Central 74 (16%) 157 (11%) 165 (8%) 129 (10%) 349 (12%) 302 (9%) 239 (5%) 213 (6%) 300 (6%) 312 (5%) 251 (3%) 207 (4%)
Southern 59 (13%) 118 (13%) 169 (10%) 128 (9%) 218 (9%) 125 (6%) 321 (10%) 363 (10%) 408 (7%) 365 (7%) 353 (5%) 261 (5%)
Hospital
Mission 2 (13%) 4 (50%) 1 (25%) 3 (15%) 20 (13%) 39 (13%) 119 (7%) 153 (7%) 150 (6%) 97 (6%) 70 (4%) 40 (5%)
District 223 (15%) 344 (11%) 394 (9%) 350 (9%) 545 (9%) 453 (7%) 492 (7%) 441 (7%) 649 (6%) 583 (5%) 543 (4%) 431 (4%)
Central 0 2 (50%) 27 (16%) 6 (8%) 139 (11%) 67 (10%) 72 (6%) 72 (9%) 36 (5%) 81 (5%) 63 (3%) 42 (6%)
Sex
Male 111 (13%) 166 (10%) 206 (8%) 182 (9%) 349 (9%) 258 (6%) 337 (7%) 323 (7%) 397 (6%) 371 (5%) 320 (4%) 255 (4%)
Female 114 (18%) 183 (13%) 213 (10%) 171 (10%) 336 (11%) 284 (9%) 326 (7%) 330 (8%) 411 (7%) 366 (6%) 341 (5%) 244 (5%)
Age
<2 months 23 (21%) 28 (12%) 60 (12%) 34 (10%) 66 (10%) 77 (9%) 96 (7%) 57 (8%) 74 (5%) 67 (6%) 64 (4%) 53 (6%)
2–59 months 202 (15%) 322 (11%) 362 (9%) 325 (9%) 638 (10%) 482 (7%) 587 (7%) 609 (7%) 761 (6%) 694 (5%) 612 (4%) 460 (4%)
Severity
Very severe, 2–59 months 121 (29%) 224 (24%) 257 (21%) 204 (20%) 402 (21%) 274 (15%) 371 (16%) 381 (18%) 450 (16%) 383 (14%) 368 (12%) 289 (12%)
Severe, 2–59 months 74 (8%) 91 (5%) 97 (4%) 112 (5%) 210 (5%) 191 (4%) 187 (3%) 214 (4%) 298 (3%) 292 (3%) 230 (2%) 159 (2%)
Very severe, <2 months 23 (30%) 24 (15%) 47 (17%) 30 (16%) 52 (13%) 57 (13%) 69 (10%) 42 (11%) 58 (9%) 43 (10%) 44 (8%) 33 (10%)
Severe, <2 months 0 4 (6%) 12 (6%) 4 (2%) 12 (5%) 19 (5%) 23 (4%) 14 (4%) 16 (2%) 21 (3%) 17 (2%) 17 (3%)
Weight
Normal 131 (12%) 184 (9%) 254 (8%) 199 (7%) 404 (8%) 323 (6%) 425 (5%) 417 (6%) 524 (5%) 493 (4%) 422 (3%) 317 (3%)
Moderately underweight 60 (24%) 81 (14%) 83 (11%) 72 (11%) 146 (14%) 112 (10%) 113 (9%) 124 (10%) 144 (8%) 131 (7%) 130 (7%) 92 (7%)
Severely underweight 34 (19%) 85 (20%) 85 (16%) 88 (19%) 154 (20%) 124 (16%) 145 (17%) 125 (15%) 167 (16%) 137 (14%) 124 (12%) 104 (15%)
Malnutrition
Severe acute malnutrition 22 (34%) 45 (26%) 46 (28%) 31 (36%) 47 (34%) 34 (28%) 56 (31%) 43 (34%) 76 (45%) 41 (30%) 19 (18%) 24 (35%)
Days with symptoms
<21 days 208 (15%) 333 (11%) 374 (9%) 302 (9%) 600 (9%) 477 (7%) 570 (7%) 566 (7%) 720 (6%) 645 (5%) 572 (4%) 432 (4%)
>21 days 12 (29%) 9 (14%) 16 (14%) 20 (14%) 49 (18%) 34 (15%) 37 (12%) 31 (10%) 48 (13%) 46 (14%) 17 (6%) 23 (9%)
Type of referral
Self-referral 131 (12%) 207 (9%) 244 (8%) 216 (8%) 386 (8%) 296 (6%) 356 (6%) 304 (5%) 394 (4%) 368 (4%) 315 (3%) 247 (3%)
Referred from a health 
centre
83 (26%) 120 (19%) 132 (13%) 93 (10%) 236 (15%) 180 (10%) 230 (10%) 253 (13%) 297 (11%) 265 (9%) 231 (7%) 181 (9%)
Previous treatment
No previous antibiotic 126 (13%) 209 (10%) 243 (9%) 169 (8%) 328 (8%) 236 (7%) 287 (6%) 251 (6%) 287 (4%) 319 (5%) 225 (3%) 173 (3%)
Previous antibiotic 74 (21%) 105 (16%) 114 (10%) 106 (10%) 227 (12%) 181 (8%) 217 (8%) 224 (10%) 314 (8%) 244 (6%) 246 (6%) 174 (7%)
Previous pneumonia in the past 12 months
No 189 (15%) 296 (11%) 339 (9%) 286 (9%) 525 (10%) 451 (7%) 507 (7%) 519 (8%) 629 (6%) 539 (5%) 489 (4%) 370 (5%)
Yes 33 (14%) 49 (10%) 65 (10%) 51 (8%) 111 (9%) 80 (7%) 118 (7%) 86 (5%) 135 (6%) 132 (5%) 98 (3%) 71 (3%)
Admission to hospital for pneumonia in the last 12 months
No 203 (15%) 319 (12%) 361 (9%) 302 (9%) 556 (9%) 470 (7%) 551 (7%) 541 (7%) 666 (6%) 570 (5%) 526 (4%) 403 (5%)
Yes 19 (15%) 26 (9%) 44 (12%) 34 (9%) 71 (9%) 58 (7%) 68 (6%) 63 (6%) 90 (6%) 94 (7%) 59 (3%) 40 (3%)
HIV status
Negative 0 0 3 (6%) 3 (8%) 10 (9%) 22 (9%) 35 (6%) 56 (7%) 74 (6%) 55 (5%) 39 (3%) 21 (4%)
Positive 0 1 (50 %) 0 2 (13%) 15 (21%) 24 (23%) 33 (16%) 38 (19%) 57 (21%) 29 (12%) 27 (11%) 16 (10%)
Data are n (%) of cases recorded to have died in hospital (see appendix pp 8–21 for graphs of this data and n (%) of cases recorded to have survived).
Table 4: Case fatality rates for key categories of potential risk factors for pneumonia mortality in Malawian hospitals, 2001–12
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of children (for a better assessment of nutritional status) 
were not available. Second, selection bias is possible; the 
study sample excluded a few smaller facilities, and a 
proportion of pneumonia cases in each facility might have 
been missed, or records could have been lost. Given that it 
is not possible to trace these cases, we do not know how 
these factors aﬀ ected our case fatality results. In a routine 
setting such as this study, indicators such as prior 
antibiotic treatment and previous pneumonia relied only 
on verbal report; measurement of temperature, respiratory 
rate, and weight might have been aﬀ ected by equipment 
accuracy, measurement error, or both.
Case fatality rates might have been aﬀ ected either by 
misrecording of deaths (numerator) or misrecording of 
total pneumonia cases (denominator). Selective under-
recording of deaths, with case selection towards more 
healthy cases, might have occurred for cases of very 
severe pneumonia dying only a few hours after hospital 
admission, or for other reasons. To this end we found a 
signifi cant increase in the proportion of cases with 
unknown outcome over time (appendix, p 24). However, 
even assuming a worst case scenario where all cases with 
an unknown outcome were ten times more likely to die 
than cases with outcome recorded, the trend of decreasing 
case fatality rate was still observed (fi gure 2). The 
multivariable logistic regression models with multiple 
imputation also support a decreasing case fatality rate 
(appendix, p 22). That pneumonia misdiagnoses might 
have occurred is possible; however, misdiagnoses are 
unlikely to have systematically increased over time to the 
extent of explaining the observed trends in case fatality 
rate reductions. Case defi nition did not change with 
time—although it changed later (WHO revised the 
pneumonia classifi cation criteria in 2013)—and data 
quality eﬀ orts were made during this time period.6
In terms of quality of data, we note signifi cant increases 
in the percentage of cases with missing data with time, 
both on non-clinical variables and on variables 
necessitating patient measurement (appendix, pp 26–
29); however, in the latter case these trends appear to be 
independent of case severity. These fi ndings might 
suggest that the data quality decreased over time, perhaps 
due to the transition away from external support.
Despite these limitations, the study has the strength of 
representing a large sample from many hospitals in 
Malawi during a long period of time. Overall, our 
fi ndings are consistent with the results of a recent 
systematic review,3 in which the case fatality rate for 
children admitted to hospital with pneumonia in the 
African region was shown to be 3·9% (95% CI 2·7–5·5). 
According to a previous analysis of 24 hospitals using the 
yellow forms, case fatality rates for pneumonia in 
children had fallen from 18·6% in 2000 to 8·4% in 2005.6 
No other studies from sub-Saharan Africa report on 
trends of case fatality rates for hospital admissions for 
pneumonia over such a long period. In a review18 of 
trends in overall mortality from respiratory diseases in 
Latin America between 1998 and 2009, investigators 
reported that mortality in children younger than 5 years 
had also signifi cantly decreased. The results of this study 
are in line with the progress documented by oﬃ  cial 
country indicators of Malawi (appendix, p 31), showing 
an improvement in many socioeconomic and health 
indicators. Several factors might have contributed to 
these achievements: extensive external support provided 
by CLHP between 2000 and 2008 (training, supervision, 
and supply of antibiotic drugs);6 improved use of oxygen 
therapy;19 strengthened community-case management;20 
and scale-up of antiretroviral drugs for HIV treatment.21,22
Overall, our multivariable results are mainly in line 
with previous analyses from low-income and middle-
income countries in Africa and Asia. Severity of 
pneumonia, malnutrition, and young age are well known 
risk factors for pneumonia mortality.23 In a systematic 
review23 of 23 studies (20 835 children), female sex was 
associated with a 15% increase in the risk of death. The 
association between clinically suspected P jirovecii 
pneumonia and high risk of death has been confi rmed in 
other studies.24–26 Longer symptom duration has also 
been associated with higher mortality in Central African 
Republic, Zimbabwe, and Papua New Guinea,27–29 and 
seasonality in pneumonia mortality has been observed in 
a nearby country (Kenya),30 and might be explained by a 
higher prevalence of non-severe viral infections in a 
certain part of the year or by other factors.31 Our fi nding 
of lower mortality in children (2–11 months of age) with 
fast breathing, after adjusting for confounders, could 
suggest that these children are less severely ill than those 
without fast breathing, an observation consistent with 
other studies in the Central African Republic27 and 
Indonesia.32
The observation that children referred to hospital from 
a health centre were more likely to die than those who 
were not referred could have multiple explanations: more 
severe cases might tend to seek care at the nearest facility, 
usually a health centre, rather than directly travelling 
longer distances to the closest hospital, or incorrect 
outpatient treatment, including delayed referral, might 
aﬀ ect mortality. Findings on fever should be interpreted 
in view of temperature being recorded only once at time 
of admission to hospital.
Results from this study have implications for practice 
by emphasising the importance of eﬀ ective national 
systems of data collection. Importantly, results from this 
database, which contains only cases of hospitalised 
pneumonia, cannot be generalised to the epidemiology 
of pneumonia mortality in the community, which is 
estimated to be greater.3 Large projects, including both 
hospital-based and community-based data are needed to 
estimate the overall risk of mortality from pneumonia in 
children in Malawi.
Despite these encouraging fi ndings, our analysis also 
reveals areas for priority action. Case fatality rates for 
hospitalised pneumonia in Malawi remain high for 
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children with very severe pneumonia, malnutrition, long 
duration of symptoms, and young age. A high case 
fatality rate for hospitalised pneumonia in girls compared 
with boys, with a lower number of girls than boys 
admitted to hospital, suggests possible sex in equalities in 
access to care or quality of treatment. This aspect, 
together with regional diﬀ erences in case fatality rates, 
deserves further assessment. The high proportion of 
children accessing the hospital through self-referral 
(78%), suggests that more needs to be done to strengthen 
primary health-care services and to improve coordination 
between levels of care.
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Supplementary Figure 3. Number of cases enrolled over time  
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Supplementary Table 1. Number of cases by region and by type of facility 
 
Region 
Type of hospital 
 
District 
 
Central 
 
Mission 
 
Total 
 
North  
 (%) 
 
 
16052 
(76.6) 
 
2574 
(12.3) 
 
2321 
(11.1) 
 
20947 
(18.5) 
 
Central 
 (%) 
 
 
35892 
(73.6) 
 
5826 
(11.9) 
 
7063 
(14.5) 
 
48781 
(43.1) 
 
South  
(%) 
 
 
37270 
(85.9) 
 
1799 
(4.1) 
 
4346 
(10.0) 
 
43415 
(38.4) 
 
 
Total 
(%) 
 
89214 
(78.9) 
 
10199 
(9.0) 
 
13730 
(12.1) 
 
113394 
(100) 
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Supplementary Figure 4.  Case fatality rate  over time by age for each of the first six months  
 
 
CFR= Case Fatality Rate 
 
Months 
old 
Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
0 
Survived 
  (%) 
34 
(73.9) 
65 
(84.4) 
139 
(84.2) 
101 
(84.2) 
186 
(85.3) 
277 
(89.6) 
398 
(89.4) 
203 
(88.3) 
385 
(93.4) 
270 
(92.8) 
265 
(93.6) 
151 
(91.5) 
Died 
  (%) 
12 
(26.1) 
12 
(15.6) 
26 
(15.8) 
19 
(15.8) 
32 
(14.7) 
32 
(10.4) 
47 
(10.6) 
27 
(11.7) 
27 
(6.6) 
21 
(7.2) 
18 
(6.4) 
14 
(8.5) 
1 
Survived 
  (%) 
53 
(82.8) 
133 
(89.3) 
294 
(89.6) 
217 
(93.5) 
420 
(92.5) 
538 
(92.3) 
804 
(94.3) 
503 
(94.4) 
1021 
(95.6) 
791 
(94.5) 
1157 
(96.2) 
670 
(94.5) 
Died 
  (%) 
11 
(17.2) 
16 
(10.7) 
34 
(10.4) 
15 
(6.5) 
34 
(7.5) 
45 
(7.7) 
49 
(5.7) 
30 
(5.6) 
47 
(4.4) 
46 
(5.5) 
46 
(3.8) 
39 
(5.5)  
2 
Survived 
  (%) 
48 
(77.4) 
87 
(82.1) 
199 
(86.9) 
158 
(84.9) 
333 
(85.4) 
372 
(91.4) 
595 
(91.8) 
443 
(90.2) 
813 
(92.3) 
730 
(94.4) 
1014 
(93.9) 
624 
(93.0) 
Died  
  (%) 
14 
(22.6) 
19 
(17.9) 
30 
(13.1) 
28 
(15.1) 
57 
(14.6) 
35 
(8.6) 
53 
(8.2) 
48 
(9.8) 
68 
(7.7) 
43 
(5.6) 
66 
(6.1) 
47 
(7.0) 
3 
Survived 
  (%) 
85 
(78.7) 
156 
(84.3) 
253 
(84.6) 
250 
(81.7) 
412 
(80.5) 
485 
(88.8) 
631 
(89.4) 
480 
(86.3) 
903 
(92.0) 
803 
(92.4) 
1075 
(94.1) 
716 
(92.3) 
Died  
  (%) 
23 
(21.3) 
29 
(15.7) 
46 
(15.4) 
56 
(18.3) 
100 
(19.5) 
61 
(11.2) 
75 
(10.6) 
76 
(13.7) 
79 
(8.0) 
66 
(7.6) 
68 
(5.9) 
60 
(7.7) 
4 
Survived 
  (%) 
99 
(81.1) 
195 
(90.3) 
246 
(87.2) 
202 
(80.8) 
426 
(87.5) 
476 
(88.6) 
566 
(90.3) 
497 
(87.7) 
818 
(93.2) 
805 
(92.4) 
948 
(94.5) 
588 
(93.3) 
Died  
  (%) 
23 
(18.9) 
21 
(9.7) 
36 
(12.8) 
48 
(19.2) 
61 
(12.5) 
61 
(11.4) 
61 
(9.7) 
70 
(12.3) 
60 
(6.8) 
66 
(7.6) 
55 
(5.5) 
42 
(6.7) 
5 
Survived 
  (%) 
63 
(79.7) 
180 
(87.4) 
252 
(92.6) 
196 
(89.1) 
411 
(89.9) 
359 
(90.4) 
469 
(90.9) 
440 
(91.1) 
705 
(93.1) 
814 
(93.3) 
899 
(95.6) 
577 
(93.4) 
Died  
  (%) 
16 
(20.3) 
26 
(12.6) 
20 
(7.4) 
24 
(10.9) 
46 
(10.1) 
38 
(9.6) 
47 
(9.1) 
43 
(8.9) 
52 
(6.9) 
58 
(6.7) 
41 
(4.4) 
41 
(6.6) 
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Supplementary Figure 5.  Case fatality rate over time by region  
 
 
 
CFR= Case Fatality Rate 
 
Region Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
N
or
th
er
n 
 
Survived 
  (%) 
453 
(83.1) 
633 
(89.4) 
933 
(91.4) 
937 
(90.2) 
1568 
(92.0) 
1766 
(93.1) 
2104 
(94.5) 
1613 
(94.7) 
2417 
(95.0) 
2150 
(96.2) 
2090 
(96.7) 
1649 
(97.3) 
Died 
  (%) 
92 
(16.9) 
75 
(10.6) 
88 
(8.6) 
102 
(9.8) 
137 
(8.0) 
132 
(7.0) 
123 
(5.5) 
90 
(5.3) 
127 
(5.0) 
84 
(3.8) 
72 
(3.3) 
45 
(2.7) 
Ce
nt
ra
l  Survived 
  (%) 
389 
(84.0) 
1337 
(89.5) 
1846 
(91.8) 
1224 
(90.5) 
2615 
(88.2) 
3203 
(91.4) 
4280 
(94.7) 
3364 
(94.1) 
4899 
(94.2) 
6422 
(95.4) 
7135 
(96.6) 
4618 
(95.7) 
Died 
  (%) 
74 
(16.0) 
157 
(10.5) 
165 
(8.2) 
129 
(9.5) 
349 
(11.8) 
302 
(8.6) 
239 
(5.3) 
213 
(6.0) 
300 
(5.8) 
312 
(4.6) 
251 
(3.4) 
207 
(4.3) 
So
ut
he
rn
 
Survived 
  (%) 
415 
(87.6) 
777 
(86.8) 
1460 
(89.6) 
1385 
(91.5) 
2361 
(91.5) 
2051 
(94.3) 
2918 
(90.1) 
3429 
(90.4) 
5507 
(93.1) 
5156 
(93.4) 
6748 
(95.0) 
4579 
(94.6) 
Died  
  (%) 
59 
(12.5) 
118 
(13.2) 
169 
(10.4) 
128 
(8.5) 
218 
(8.5) 
125 
(5.7) 
321 
(9.9) 
363 
(9.6) 
408 
(6.9) 
365 
(6.6) 
353 
(5.0) 
261 
(5.4) 
 
 
 
For all geographical regions, the CFR was significantly higher in 2001 compared to 2012 (Supplementary 
Figure 5):  Southern Malawi (12.4%, CI 9.8% to 15.7% vs. 5.4%, CI 4.8% to 6.1%; p< 0.001); Central 
Malawi (16.0%, CI 12.9% to 19.6% vs. 4.3%, CI 3.8% to 4.9%; p< 0.001); Northern Malawi (16.9%, CI 
14.0% to 20.2% vs. 2.7%, CI 2.0% to 3.5%; p< 0.001). There were some significant differences in CFR 
between regions over time, with Southern Malawi showing from year 2007 a significantly higher CFR 
compared to Northern and Central Malawi (Supplementary Figure 5).   
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Supplementary Figure 6.  Case fatality rate over time by type of hospital 
 
 
 
CFR= Case Fatality Rate 
 
Note: Large confidence intervals for CFRs of Mission and Central hospitals during year 2003 to 2006 are explained by the 
small number of hospitals enrolled at that time, and a relative low number of events.  The scaling up of data collection 
through the Yellow Form started with district hospitals in 2001, and progressively enclosed Central Hospitals in year 
2003, and CHAM hospitals from year 2005. 
 
Hosp. Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
M
is
si
on
  Survived 
  (%) 
14 
(87.5) 
4 
(50.0) 
3 
(75.0) 
17 
(85.0) 
134 
(87.0) 
264 
(87.1) 
1668 
(93.3) 
1925 
(92.6) 
2590 
(94.5) 
1540 
(94.1) 
1591 
(95.8) 
834 
(95.4) 
Died 
  (%) 
2 
(12.5) 
4 
(50.0) 
1 
(25.0) 
3 
(15.0) 
20 
(13.0) 
39 
(12.9) 
119 
(6.7) 
153 
(7.4) 
150 
(5.5) 
97 
(5.9) 
70 
(4.2) 
40 
(4.6) 
D
is
tr
ic
t 
 Survived 
  (%) 
1240 
(84.8) 
2741 
(88.9) 
4098 
(91.2) 
3458 
(90.8) 
5258 
(90.6) 
6171 
(93.2) 
6502 
(93.0) 
5727 
(92.9) 
9488 
(93.6) 
10600 
(94.8) 
12588 
(95.9) 
9334 
(95.6) 
Died 
  (%) 
223 
(15.2) 
344 
(11.2) 
394 
(8.8) 
350 
(9.2) 
545 
(9.4) 
453 
(6.8) 
492 
(7.0) 
441 
(7.1) 
649 
(6.4) 
583 
(5.2) 
543 
(4.1) 
431 
(4.4) 
Ce
nt
ra
l Survived 
  (%) 
3 
(100) 
2 
(50.0) 
138 
(83.6) 
71 
(92.2) 
1152 
(89.2) 
585 
(89.7) 
1132 
(94.0) 
754 
(91.3) 
745 
(95.4) 
1588 
(95.1) 
1794 
(96.6) 
678 
(94.2) 
Died  
  (%) 
0 
(0) 
2 
(50.0) 
27 
(16.4) 
6 
(7.8) 
139 
(10.8) 
67 
(10.3) 
72 
(6.0) 
72 
(8.7) 
36 
(4.6) 
81 
(4.9) 
63 
(3.4) 
42 
(5.8) 
 
 
 
All healthcare facility types showed a significant decrease in CFRs (Supplementary Figure 6): district 
hospitals (15.2%, CI 13.5% to 17.2% in 2001 vs. 4.4%, CI 4.0% to 4.8% in 2012; p< 0.001); central 
hospitals (16.4%, CI 11.5% to 22.8% in 2003 vs. 5.8%, CI 4.3% to 7.8% in 2012; p< 0.001); mission 
hospital (13.0%, CI 8.5% to 19.3% in 2005 vs. 4.6%, CI 3.4% to 6.2% in 2012; p< 0.001). 
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Supplementary Figure 7. Case fatality rate over time by sex 
 
 
 
CFR= Case Fatality Rate 
 
Sex Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
M
al
e 
 
Survived 
  (%) 
719 
(86.6) 
1451 
(89.7) 
2240 
(91.6) 
1914 
(91.3) 
3542 
(91.0) 
3852 
(93.7) 
4872 
(93.5) 
4582 
(93.4) 
6862 
(94.5) 
7586 
(95.3) 
8743 
(96.5) 
6029 
(95.9) 
Died 
  (%) 
111 
(13.4) 
166 
(10.3) 
206 
(8.4) 
182 
(8.7) 
349 
(9.0) 
258 
(6.3) 
337 
(6.5) 
323 
(6.6) 
397 
(5.5) 
371 
(4.7) 
320 
(3.5) 
255 
(4.1) 
Fe
m
al
e Survived 
  (%) 
538 
(82.5) 
1282 
(87.5) 
1979 
(90.3) 
1606 
(90.4) 
2879 
(89.5) 
3029 
(91.4) 
4186 
(92.8) 
3671 
(91.8) 
5661 
(93.2) 
5821 
(94.1) 
6845 
(95.3) 
4599 
(95.0) 
Died 
  (%) 
114 
(17.5) 
183 
(12.5) 
213 
(9.7) 
171 
(9.6) 
336 
(10.5) 
284 
(8.6) 
326 
(7.2) 
330 
(8.2) 
411 
(6.8) 
366 
(5.9) 
341 
(4.7) 
244 
(5.0) 
 
 
 
The CFR significantly decreased during the period 2001 to 2012 for both females (17.5%, CI 14.8% to 
20.6% vs. 5.0%, CI 4.5% to 5.7%; p< 0.001) and males (13.4%, CI 11.2% to 15.9% vs. 4.1%, CI 3.6% to 
4.6%; p< 0.001; Supplementary Figure 7). Overall mortality was significantly higher in females compared to 
males (3400/46138 (7.4%) vs. 3333/56570 (5.9%), OR 1.27, CI 1.21 to 1.34) and a significant difference in 
CFRs by sex category was found in most of the study years.  
0% 
2% 
4% 
6% 
8% 
10% 
12% 
14% 
16% 
18% 
20% 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
 M
ea
n 
CF
R 
(9
5%
CI
) 
Year of admission 
Male Female  
!! 12 
Supplementary Figure 8.  Case fatality rate over time by age classes   
 
 
  
CFR= Case Fatality Rate !
Age Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
<
2 
m
o 
 Survived 
  (%) 
87 
(79.1) 
198 
(87.6) 
433 
(87.8) 
318 
(90.3) 
606 
(90.2) 
815 
(91.4) 
1202 
(92.6) 
706 
(92.5) 
1406 
(95.0) 
1061 
(94.1) 
1422 
(95.7) 
821 
(93.9) 
Died 
  (%) 
23 
(20.9) 
28 
(12.4) 
60 
(12.2) 
34 
(9.7) 
66 
(9.8) 
77 
(8.6) 
96 
(7.4) 
57 
(7.5) 
74 
(5.0) 
67 
(5.9) 
64 
(4.3) 
53 
(6.1) 
2-
59
 m
o Survived 
  (%) 
1171 
(85.3) 
2549 
(88.8) 
3806 
(91.3) 
3228 
(90.9) 
5939 
(90.3) 
6205 
(92.8) 
8100 
(93.2) 
7700 
(92.7) 
11418 
(93.8) 
12669 
(94.8) 
14552 
(96.0) 
10028 
(95.6) 
Died 
  (%) 
202 
(14.7) 
322 
(11.2) 
362 
(8.7) 
325 
(9.1) 
638 
(9.7) 
482 
(7.2) 
587 
(6.8) 
609 
(7.3) 
761 
(6.2) 
694 
(5.2) 
612 
(4.0) 
460 
(4.4) 
 
 
 
The CFR significantly decreased during the period 2001 to 2012 in both young infants <2 months (20.9%, CI 
14.3% to 29.6% vs. 6.1%, CI 4.7% to 7.9%; p< 0.001; Supplementary Figure 8) and children 2-59 months 
(14.7%, CI 12.9% to 16.7% vs. 4.4%, CI 4.0% to 4.8%; p< 0.001). Overall, mortality was significantly 
higher in young infants than in children (712/9959 (7.2%) vs. 6191/94973 (6.5%), OR 1.10, CI 1.02 to 
1.20), although when results were compared by study year, there was a statistically significant difference in 
annual CFR only in 2003 and 2012.   
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Supplementary Figure 9.  Case fatality rate over time by severity of pneumonia    !
!!
CFR= Case Fatality Rate  
 
Severity Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
Ve
ry
  
Se
ve
re
 
2-
59
 m
o Survived 
  (%) 
303 
(71.5) 
730 
(76.5) 
957 
(78.8) 
796 
(79.6) 
1478 
(78.6) 
1508 
(84.6) 
1909 
(83.7) 
1737 
(82.0) 
2399 
(84.2) 
2276 
(85.6) 
2679 
(87.9) 
2129 
(88.1) 
Died 
  (%) 
121 
(28.5) 
224 
(23.5) 
257 
(21.2) 
204 
(20.4) 
402 
(21.4) 
274 
(15.4) 
371 
(16.3) 
381 
(18.0) 
450 
(15.8) 
383 
(14.4) 
368 
(12.1) 
289 
(11.9) 
Se
ve
re
 
2-
59
 m
o 
 
Survived 
  (%) 
807 
(91.6) 
1705 
(94.9) 
2704 
(96.5) 
2343 
(95.4) 
4264 
(95.3) 
4520 
(95.9) 
5870 
(96.9) 
5685 
(96.4) 
8703 
(96.7) 
10044 
(97.2) 
11491 
(98.0) 
7687 
(98.0) 
Died 
  (%) 
74 
(8.4) 
91 
(5.1) 
97 
(3.5) 
112 
(4.6) 
210 
(4.7) 
191 
(4.1) 
187 
(3.1) 
214 
(3.6) 
298 
(3.3) 
292 
(2.8) 
230 
(2.0) 
159 
(2.0) 
Ve
ry
  
Se
ve
re
 
<
2 
m
o 
Survived 
  (%) 
54 
(70.1) 
133 
(84.7) 
237 
(83.5) 
155 
(83.8) 
335 
(86.6) 
400 
(87.5) 
593 
(89.6) 
346 
(89.2) 
581 
(90.9) 
375 
(89.7) 
504 
(92.0) 
288 
(89.7) 
Died  
  (%) 
23 
(29.9) 
24 
(15.3) 
47 
(16.5) 
30 
(16.2) 
52 
(13.4) 
57 
(12.5) 
69 
(10.4) 
42 
(10.8) 
58 
(9.1) 
43 
(10.3) 
44 
(8.0) 
33 
(10.3) 
Se
ve
re
 
<
2 
m
o Survived 
  (%) 
32 
(100) 
60 
(93.8) 
192 
(94.1) 
160 
(97.6) 
257 
(95.5) 
406 
(95.5) 
589 
(96.2) 
352 
(96.2) 
810 
(98.1) 
664 
(96.9) 
887 
(98.1) 
516 
(96.8) 
Died  
  (%) 
0 
(0) 
4 
(6.3) 
12 
(5.9) 
4 
(2.4) 
12 
(4.5) 
19 
(4.5) 
23 
(3.8) 
14 
(3.8) 
16 
(1.9) 
21 
(3.1) 
17 
(1.9) 
17 
(3.2) 
 
 
 
Over time there was a significant decrease in CFR both for cases of very severe pneumonia in children aged 
2-59 months (28.5%, CI 24.4% to 33.0% vs. 12.0%, CI 10.7% to 13.3% vs.; p< 0.001), severe pneumonia 
in children aged 2-59 months (8.4%, CI 6.7% to 10.4% vs. 2.0%, CI 1.7% to 2.4%; p< 0.001), and very 
severe pneumonia in young infants <2 months (29.9%, CI 20.7% to 41.0% vs. 10.3%, CI 7.4% to 14.1%; 
p< 0.001; Supplementary Figure 9). There was less of a decrease over time in CFR for severe pneumonia in 
young infants <2 months (6.3%, CI 2.3% to 15.6% in 2002 vs. 3.2%, CI 2.0% to 5.1% in 2012; p= 0.02). 
Overall mortality was significantly higher for very severe pneumonia compared to severe pneumonia both in 
children (3804/22990 (16.6%) vs. 2206/69078 (3.2%) OR 6.01, CI 5.69 to 6.35) and in young infants 
(528/4610 (11.5%) vs. 165/5175 (3.2%) OR 3.93, CI 3.28 to 4.70), and such difference was appreciable 
throughout the whole study period (Supplementary Figure 9).  
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Supplementary Figure 10.  Case fatality rate over time in children with normal weight and in 
underweight children 
 
 
 
CFR= Case Fatality Rate 
 
Note: moderate underweight was defined as weight-for-age <-2 standard deviation (SD) from the mean based on the 
WHO 2006 growth reference standards;1  severe underweight was defined as weight-for-age <-3 SD based on the WHO 
2006 growth reference standards.1   
 
Weight Cases (n) 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
N
or
m
al
  Survived 
  (%) 
923 
(87.6) 
1886 
(91.1) 
3103 
(92.4) 
2595 
(92.9) 
4996 
(92.5) 
5372 
(94.3) 
7396 
(94.6) 
6606 
(94.1) 
10354 
(95.2) 
11260 
(95.8) 
13331 
(96.9) 
9049 
(96.6) 
Died 
  (%) 
131 
(12.4) 
184 
(8.9) 
254 
(7.6) 
199 
(7.1) 
404 
(7.5) 
323 
(5.7) 
425 
(5.4) 
417 
(5.9) 
524 
(4.8) 
493 
(4.2) 
422 
(3.1) 
317 
(3.4) 
M
od
er
at
e 
U
nd
er
-
w
ei
gh
t Survived   (%) 
192 
(76.2) 
510 
(86.3) 
683 
(89.2) 
571 
(88.8) 
912 
(86.2) 
971 
(89.7) 
1205 
(91.4) 
1112 
(90.0) 
1566 
(91.6) 
1631 
(92.6) 
1757 
(93.1) 
1227 
(93.0) 
Died 
  (%) 
60 
(23.8) 
81 
(13.7) 
83 
(10.8) 
72 
(11.2) 
146 
(13.8) 
112 
(10.3) 
113 
(8.6) 
124 
(10.0) 
144 
(8.4) 
131 
(7.4) 
130 
(6.9) 
92 
(7.0) 
Se
ve
re
 
U
nd
er
-
w
ei
gh
t Survived   (%) 
143 
(80.8) 
351 
(80.5) 
453 
(84.2) 
380 
(81.2) 
637 
(80.5) 
677 
(84.5) 
701 
(82.9) 
688 
(84.6) 
904 
(84.4) 
839 
(86.0) 
886 
(87.7) 
573 
(84.6) 
Died  
  (%) 
34 
(19.2) 
85 
(19.5) 
85 
(15.8) 
88 
(18.8) 
154 
(19.5) 
124 
(15.5) 
145 
(17.1) 
125 
(15.4) 
167 
(15.6) 
137 
(14.0) 
124 
(12.3) 
104 
(15.4) 
 
 
When CFR was stratified by nutritional status a significant decrease in CFR from year 2001 to 2012 was 
observed in WHO-defined well-nourished children (12.4%, CI 10.6% to 14.6% vs. 3.4%, CI 3.0% to 3.8%; 
p< 0.001) and in children moderately underweight per WHO criteria (23.8%, CI 18.9% to 29.5% vs. 7.0%, 
CI 5.7% to 8.5%, p< 0.001; Supplementary Figure 10). In children severely underweight by WHO standards 
and with NCHS-defined severe acute malnutrition mortality did not significantly change over time 
(Supplementary Figures 10 and 11). Compared to well-nourished children, CFR were significantly higher for 
children WHO moderately underweight (3237/75746 (4.3%) vs. 1315/13824 (9.5%), OR 2.35, CI 2.20 to 
2.52) and WHO severely underweight (1396/8741 (16.0%), OR 4.26, CI 3.98 to 4.55). Children with NCHS-
defined severe acute malnutrition also had significantly higher CFR (488/1556 (31.4%) than those without 
(5227/87689 (6.0%), OR 7.21, CI 6.45 to 8.05). A significant difference in CFR by children with different 
nutritional status was appreciable in each year of the study.  
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Supplementary Figure 11.  Case fatality rate over time in children with severe acute 
malnutrition  
 
 
 
 
CFR= Case Fatality Rate 
 
Note: The diagnosis of severe acute malnutrition was made prospectively during patient care by the health worker per 
the National Centre for Health Statistics (NCHS) criteria used for standard clinical care in Malawi.12, 13  
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Supplementary Figure 12.  Case fatality rate over time by duration of the disease 
 
 
 
CFR= Case Fatality Rate 
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A significant decrease in CFR from 2001 to 2012 was observed in children hospitalised with symptoms lasting 
less than 21 days (14.7%, CI 13.0% to 16.7% vs. 4.3%, CI 3.9% to 4.7%; p< 0.001), but not for those 
with symptoms lasting 21 days or more (Supplementary Figure 12). Overall mortality was significantly higher 
in children with disease duration >21 days (350/2801 (12.5%) vs. 5897/93134 (6.3%), OR 2.11, CI 1.88 to 
2.37).  
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Supplementary Figure 13.  Case fatality rate over time by type of access  
 
 
 
 
CFR= Case Fatality Rate 
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For children referred to the hospital by a health centre, CFR was significantly lower in 2012 compared to 
2001 (9.2%, CI 8.0% to 10.6% vs. 26.2%, CI 21.6% to 31.3%; p< 0.001), as was CFR for those who were 
self-referred (2.9%, CI 2.6% to 3.2% vs. 11.8%, CI 10.1% to 13.9%; p< 0.001, Supplementary Figure 13). 
Mortality was significantly higher in children referred from health centres than from children self-referred, 
throughout the study period (2329/21668 (10.8%) vs. 3522/69185 (5.1%), OR 2.25, CI 2.13 to 2.37. 
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Supplementary Figure 14.  Case fatality rate over time in children receiving and not receiving 
antibiotics before the hospitalisation.   
 
!!
CFR= Case Fatality Rate 
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CFRs significantly decreased both in children receiving an antibiotic before hospitalisation (20.6%, CI 16.7% 
to 25.1% vs. 6.6%, CI 5.7% to 7.6%%; p< 0.001) and in those not receiving it (12.5%, CI 10.7% to 14.8%  
vs. 3.2%, CI 2.7% to 3.7%; p< 0.001, Supplementary Figure 14), with children receiving antibiotics being 
associated with an higher odds of death (2255/27385 (8.2%) vs. 2893/51542 (5.6%), OR 1.51, CI 1.43 to 
1.60), probably due to initial prescription of antibiotics by community health workers being more likely in 
more severe cases as per IMCI guidelines.   
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Supplementary Figure 15.  Case fatality rate over time in children with and without an episode 
of pneumonia in the previous 12 months  
 
!!
CFR= Case Fatality Rate 
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CFR significantly decreased both in children with or without an episode of pneumonia in the previous 12 
months (with pneumonia: CFR 14.3%, CI 10.3% to 19.4% vs. 3.3%, CI 2.6% to 4.1%; p< 0.001; without 
pneumonia in the previous 12 months: CFR 15.3%, CI 13.4% to 17.4% vs. 4.6%, CI 4.1% to 5.0%, p< 
0.001; Supplementary Figure 15), as well as in children with or without a pneumonia hospitalisation in the 
previous 12 months (with hospitalisation: CFR 14.5% CI 9.4% to 21.7% vs. 2.7% CI 2.0% to 3.7%; p< 
0.001; without hospitalisation: CFR 15.2% CI 13.3%. to 17.2% vs. 4.6% CI 4.2% to 5.0%, p< 0.001; 
Supplementary Figure 16). Overall mortality was significantly lower in children with a previous diagnosis of 
pneumonia (1040/17744 (5.9%) vs. 5235/79544 (6.6%), OR 0.88, CI 0.83 to 0.95) or with a previous 
pneumonia hospitalisation (673/11578 (5.8%) vs. 5566/85440 (6.5%), OR 0.89, CI 0.82 to 0.96). 
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Supplementary Figure 16.  Case fatality rate over time in children with and without 
hospitalisation for pneumonia in the previous 12 months  
 
!!
CFR= Case Fatality Rate 
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Supplementary Figure 17.  Case fatality rate over time by HIV status  
 
!!
CFR= Case Fatality Rate 
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CFR significantly decreased both in children HIV negative and HIV positive (Supplementary Figure 17). The 
analysis included cases after year 2005 (i.e. from when a sufficient number of cases with data on HIV are 
available)  A separate logistic regression models of pneumonia mortality for HIV negative and HIV positive 
cases, with year of admission as a covariate found that mortality declined in both populations: HIV negative: 
adjusted Odds Ratio of mortality per year: 0.90 (95%CI: 0.85, 0.95, p=0.000, n=6304; HIV positive: 
adjusted Odds Ratio of mortality per year: 0.88 (95%CI: 0.82, 0.94, p=0.000, n=1538). 
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Supplementary Table 2: Multiple Imputation Mixed effects multivariable regression analysis showing 
odds ratio (95% CI) for risk factors for mortality in children under 2 months of age, 2-11 and 12-59 
months old.  
Risk factor 
Under 2 months 
AOR (95% CI) 
2-11 months old 
AOR (95% CI) 
12-59 months old 
AOR (95% CI) 
Region    
Northern - 1.00 - 
Central - 1.13 (0.87 – 1.45) - 
Southern - 1.50 (1.16 – 1.93) - 
Sex    
Male - 1.00 1.00 
Female - 1.37 (1.29 – 1.47) 1.38 (1.25 - 1.52) 
Pneumonia classificationa    
Pneumonia N/A 1.00 1.00 
Severe pneumonia 1.00 1.97 (1.26 – 3.10) 1.02 (0.68 – 1.55) 
Very severe pneumonia 3.32 (2.71 – 4.06) 10.38 (6.62 – 16.12) 5.26 (3.46 – 7.92) 
Pneumocystis jiroveci  5.58 (1.49 – 21.12)c 17.81 (10.28 – 30.57) 4.95 (2.03 – 12.18) 
Days with symptoms    
Less than 21 days - 1.00 - 
More than 21 days - 1.37 (1.16 – 1.61) - 
Type of referral    
Self referral  1.00 1.00 1.00 
From health centre 1.80 (1.50 - 2.16) 1.59 (1.48 – 1.71) 2.16 (1.88 – 2.48) 
Measles in last 2 months    
No  - 1.00 - 
Yes - 1.25 (0.96 – 1.61) - 
Age for weight    
Normal weight 1.00 1.00 1.00 
Moderately underweight 3.16 (2.48 – 4.01) 2.20 (2.01 – 2.39) 1.82 (1.57 – 2.10) 
Severely underweight 3.63 (2.56 – 5.21) 3.35 (3.03 – 3.71) 3.32 (2.83 – 3.86) 
Severe Acute Malnutrition    
Absent - 1.00 1.00 
Present - 3.13 (2.57 – 3.82) 3.90 (3.22 – 4.76) 
Temperature    
Afebrile 1.00 - - 
Febrile (>38°C) 1.45 (1.17 – 1.80) - - 
Season    
Dry (May - October) 1.00 - 1.00 
Wet (November - April) 0.73 (0.62 – 0.86) - 1.14 (1.02, 1.26) 
Respiratory category     
normal - 1.00 - 
Fast breathingb  - 0.82 (0.71 – 0.93) - 
Year admitted to hospital 
Per year, 2001 to 2012 0.92 (0.90 – 0.96) 0.91 (0.90 – 0.93) 0.93 (0.91 – 0.95) 
Age in months 
Per month within age group 0.55 (0.46 – 0.64) 0.95 (0.94 – 0.96) - 
N/A= not applicable 
- = not included in final multivariable model 
a See Panel for definitions 
b>60 breaths/minute if <2 months old, >50 breaths/minute 2-11 months old; >40 breaths/minute if 12-59 months old 
c"statistically significant at the p<0.05 level with multiple imputation when it was not statistically significant without multiple imputation 
!
!! 23 
Supplementary Figure 18.  Trends in variables related to treatment outcomes and mortality 
 
Our primary outcome for this analysis is mortality during hospitalisation in children under 5 admitted for 
pneumonia. Determining the numerator and denominator for hospital mortality is complicated by the 
incomplete and sometimes inconsistent filling of the yellow form (Supplementary Figure 1). As the 
numerator we have used the number of cases for which any of the forms had "Died within 24 hours" or 
"Died after 24 hours" indicated. As the denominator we have used the number of cases for which we have 
positive information that the child was either alive or dead at the end of hospitalisation. This comprises 
cases having a "yes" for any of the following variables from the Discharge and Follow-up and Treatment 
Results sections: Course of antibiotics to be completed at home, mother informed to return with child once 
antibiotics completed, child returned for follow-up visit, course of antibiotic completed (this refers to the 
antibiotics given for home treatment), child fully recovered, treatment completed, left against advice, 
transferred, and the two death categories (before and after 24 hours) previously mentioned. In instances 
where none of these variables had been completed, the outcome for total deaths was set to missing. A 
larger proportion of cases were indicated on the form as outcome unknown at time of discharge 
(Supplementary Figure 18b).  In instances of treatment failure, the outcome of mortality was also set to 
missing.  If a child has treatment failure, they will presumably be treated with different antibiotics and any 
one of the following can happen; they can either improve, they can die, get transferred or abscond.  Hence, 
in cases where the final outcome is treatment failure, we are unsure if the child lived or the child died, with 
a greater possibility of the child dying than living. For this reason, mortality was set to missing.  
 
The following figures show the trends in each of the variables used to determine treatment outcome and the 
numerator and denominator of the mortality variable. Supplementary Figure 18a shows significant 
downward trends in treatment failure at 48hrs and at 5 days as well as in death within 24hrs or after 24hrs, 
lending support to the decline in CFR shown in Figure 3 of the main paper and supplementary figures 3-14. 
 
Supplementary Figure 18a. Trends in Absconders, Deaths, Treatment Failure and Transferred Cases 
 
 
*Trends and associated p-values refer to ordinary least-squares linear regression of the variable on year of admission. 
 
 
Supplementary Figure 18b, however, shows significant increases in the percentage of cases with unknown 
outcome at time of discharge (only partially offset by discrepancies in how the form was filled), which mirror 
the percentage decrease in cases indicated to have completed treatment. This is concerning as it could 
confound the trend of decreasing CFR. It also matches a general trend for most variables to have more 
missing data in later years (Supplementary Figure 19). 
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Supplementary Figure 18b. Trends in Treatment Completed and Outcome unknown or missing 
 
 
*Trends and associated p-values refer to ordinary least-squares linear regression of the variable on year of admission. 
 
 
Supplementary Figure 18c shows significant increasing trends in Yes (rather than No responses, see 
Supplementary Figure 1) to all five of the Follow-up and Discharge variables. Unlike the Treatment outcome 
variables (Supplementary Figures 18a and 18b) these variables are not mutually exclusive. Therefore we 
also show trends on the percentage of cases with missing data on each of the five variables in 
Supplementary Figure 18d. Like many other variables (Supplementary Figure 19), the percentage of cases 
missing data on these variables are also increasing. This is again concerning as it appears to show a 
decrease in data quality over time. 
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Supplementary Figure 18c. Trends in Discharge and Follow-up variables 
 
 
 
Supplementary Figure 18d. Trends in Discharge and Follow-up variables missing data 
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Supplementary Figure 19.  Trends in missing data 
 
Supplementary Figure 19a shows no trend in the percentage of cases with missing data on classification of 
pneumonia in children aged 2-59 months, but does show a slight increase in the percentage of cases 
missing data on pneumonia classification in babies aged 0-2 months. 
 
Supplementary Figure 19b shows significant increases, some quite large, in the percentage of missing data 
for seven of the patient characteristic variables collected on the form that could have been collected 
independently of clinical examination. Figure 16c shows similar increases for the three variables requiring 
measurement of the child. If measurements are more likely to be recorded in less severe patients, when the 
clinician has more time, then these trends could suggest severe cases could be more likely to have been 
missed in earlier years, meaning our trends in CFR reduction (Figure 2, Supplementary Figures 4-17) could 
be conservative.  
 
To investigate this we further examined the trends in missing data in the three measurement variables 
(temperature, respiratory rate, and weight) by splitting them into each of the following four categories of 
severity of cases: those who died, those with very severe pneumonia, those with severe pneumonia and 
those with non-severe pneumonia (supplementary figures 19d, 19e and 19f). These figures show significant 
increasing trends for all four categories of patients, for all three measurement variables, except for weight 
measurement in non-severe cases. Given the trends in the percentage with missing data do not seem to 
differ much between dead, very severe, severe and non-severe cases, the increasing trends in missing data 
over time are unlikely to be a result of changing case mix. Therefore the increase in missing data is more 
likely to be due to changes in data collection processes. 
 
 
Supplementary Figure 19a. Trends in missing data on the severity classification variables 
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Supplementary Figure 19b. Trends in missing data on variables that could be ascertained independently of 
clinical examination 
 
 
 
Supplementary Figure 19c. Trends in missing data on variables that require measurement of the child 
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Supplementary Figure 19d. Trends in missing data for temperature measurement, by severity 
 
 
 
 
Supplementary Figure 19e. Trends in missing data for respiratory rate measurement, by severity 
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Supplementary Figure 19f. Trends in missing data for weight measurement, by severity 
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Supplementary Figure 20.  Potential impact of a decreasing trend in HIV prevalence on case fatality rate 
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Supplementary Table 3. Malawi, country indicators in the study period  
 
TYPE OF INDICATOR YEAR  
BASIC 2000 2010 2012 
Mortality rate, under-5 (per 1,000 live births) 164 83 71 
Mortality rate, under-1 (per 1,000 live births) 80 53 46 
NUTRITION     
Exclusive breastfeeding (% of children under 6 months) 44 71.9 71.4 
Low-birthweight babies (% of births) 15.9 12.5 13.5 
Underweight, moderate & severe  (% of children under 5) 21.5 13.8 12.8 
Stunting, moderate & severe (% of children under 5) 54.6 47.8 47.1 
Wasting, moderate & severe (% of children under 5) 6.8 4.1 4 
GENERAL HEALTH     
Population using an improved drinking water source  62 83 -  
Population using an improved sanitation facility 45.5 51 - 
Immunization coverage (%), BCG 83 97 99 
Immunization coverage (%), DTP3 75 93 96 
Immunization coverage (%), MCV 73 93 90 
Immunization coverage (%), Hib3 - 93 96 
Pneumonia (%), Care seeking for suspected pneumonia  26.7 70.3 70.3 
Pneumonia (%), Antibiotic treatment for suspected pneumonia  - 29.5 29.5 
Diarrhoea (%), Treatment with oral rehydration salts (ORS)  51.4 69 69 
Malaria (%), Antimalarial treatment among febrile children 27 43.4 32.5 
Malaria (%), Children sleeping under ITNs 2.9 34.9 56 
Vitamin A doses (% of children under 5) 76 40 61 
HIV/AIDS    
Children living with HIV (thousands)  - - 180 
Antiretroviral therapy coverage (% of people with advanced HIV)  - 47 69 
TUBERCULOSIS     
Tuberculosis treatment success rate (% of registered cases) 73 87 - 
Tuberculosis case detection rate (%, all forms) 45 64 68 
Incidence of tuberculosis (per 100,000 people) 467 219 163 
EDUCATION    
Total adult literacy rate (%)   - 64.8 61.3 
Primary completion rate, female (% of relevant age group) 61.8 69.6 74.7 
WOMEN     
Antenatal care, at least one visits (% pregnant women) 91.4 94.7 94.7 
DEMOGRAPHIC     
Total fertility rate 6.2 5.6 5.5 
ECONOMIC     
GNI per capita (current US$) 154 310 320 
Health expenditure per capita (current US$) 9.4 28.5 - 
Population below international poverty line of US$1.25 per day (%)  65.3 - 61.6 
Crop production index (2004-2006 = 100) 98.7 156 - 
Food production index (2004-2006 = 100) § 99 157 - 
Livestock production index (2004-2006 = 100) §§ 92 158 - 
§ Food production index: Food production index covers food crops that are considered edible and that contain nutrients. 
Coffee and tea are excluded because, although edible, they have no nutritive value.  
 §§ Livestock production index: Livestock production index includes meat and milk from all sources, dairy products such 
as cheese, and eggs, honey, raw silk, wool, and hides and skins. 
 
Abbreviations: BCG=Bacille Calmette Guerin vaccine; DTP3=third dose of diphtheria, tetanus, pertussis vaccine; Hib3= 
third dose of haemophilus influenzae type b vaccine; ITNs= Insecticide Treated Nets; MCV= measles containing vaccine  
 
Sources of data: UNICEF Malawi country indicators;2 The World Bank, World Development Indicators (last update 18 
December 2013);3 Malawi Demographic and Health Survey 2000;4  Malawi Demographic and Health Survey 2010.5
!! 32 
References 
 
1. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-
age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and 
development. . Geneva: World Health Organisation, 2006. 
2. UNICEF. Malawi country Statistics. Available at 
http://www.unicef.org/infobycountry/malawi_statistics.html (accessed 20th May 2015). 2015. 
3. World Bank. World DataBank. World Development Indicators, Malawi (available at: 
http://databank.worldbank.org/data/views/reports/chart.aspx (accessed 13th October 2014), 2014. 
4. National Statistics Office M, Macro International USA. Malawi Demographic and Health Survey 2000. 
Zomba, Malawi and Calverton, Maryland, US: NSO and Macro International Inc., 2001. 
5. National Statistical Office (NSO), ICF Macro. Malawi Demographic and Health Survey 2010. Zomba, 
Malawi, and Calverton, Maryland, USA: NSO and ICF Macro, 2011. 
 
 
